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1. Introduction and background 
1.1. Clinical aspects of hand osteoarthritis (OA) 
1.1.1 Definitions and classification criteria  
Osteoarthritis (OA) is the most common musculoskeletal disease (1) and may have 
considerable impact on health-related quality of life (2). The hand, knee and hip joints are 
most frequently affected, and hand OA usually involves the distal interphalangeal (DIP), 
proximal interphalangeal (PIP) and thumb base joints (3). Hand OA is often co-occurring 
with OA in the larger joints and may represent a marker of a generalised OA susceptibility. 
Kellgren and Moore suggested the concept of generalised OA early in the 1950s (4), and 
numerous studies have later confirmed an association between hand and knee OA and to a 
lesser extent to hip and spine OA (5-7). However, there is still no consensus about the 
definition of generalised OA, i.e., the required number and location of affected joints (8).  
OA was previously separated into primary and secondary OA based on the absence or 
presence of known prior events/diseases related to OA respectively (9). The distinction 
between these two phenotypes is currently not recommended (10).  
The diagnosis of hand OA is based on a combination of medical history, clinical 
examination, radiographs and possibly laboratory tests (in order to exclude differential 
diagnoses) (11). The American College of Rheumatology (ACR) criteria for classification 
of hand OA are the most widely used hand OA criteria in clinical and epidemiological 
studies (Table 1) (12). The criteria include major clinical hand OA characteristics but do not 
involve the entire spectrum of disease manifestations. Radiography was considered of less 
value than clinical examination for the classification of symptomatic hand OA.  
The most common method for radiographic definition of OA is the Kellgren-Lawrence (KL) 
grading scheme and atlas (13, 14). The definition of OA at a single joint (KL grade > 2) is 
consistent across studies, but there are substantial variations in the required number of 
affected joints and/or the involvement of specific hand joints (15). Radiographic hand OA 
can further be separated into erosive and non-erosive OA, although the exact criteria for the 
definition of erosive hand OA are subject of debate (16). There is also no consensus whether 
erosive hand OA represents a different subset or a severe stage of hand OA (16, 17).  
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Table 1. The American College of Rheumatology classification criteria for clinical hand 
OA (traditional format).  
Criterion: 
1. Hand pain, aching or stiffness for most days of the prior month 
and 3 of 4 following features: 
2. Hard tissue enlargement of 2 or more of 10 selected joints * 
3. Hard tissue enlargement of 2 or more distal interphalangeal joints 
4. Fewer than 3 swollen metacarpophalangeal joints * 
5. Deformity of at least 1 of 10 selected joints * 
* The 10 selected joints are the 2nd and 3rd distal interphalangeal, 2nd and 3rd proximal interphalangeal and the 
1st carpometacarpal joints of both hands.  
1.1.2 Epidemiology 
The prevalence and pattern of radiographic hand OA have been extensively studied (3, 18-
22), whereas the incidence and longitudinal course of hand OA in the general population are 
less well described (3, 23-25). The estimates show large variation, which may be due to 
differences in types of populations, disease definitions and/or risk factors such as genetic 
background or environmental exposures (26). Studies of rural societies have shown higher 
estimates of hand OA than studies of more modern Caucasian societies (3, 18-21), while the 
estimates are lower among Chinese (22). The age-standardised prevalence of radiographic 
hand OA in the Framingham OA study was similar in women and men (44% vs. 38%), 
whereas symptomatic hand OA was twice as frequent in women (14% vs. 7%) (3). OA in 
the DIP, PIP and thumb base joints were more frequent in women than in men, whereas OA 
in the metacarpophalangeal (MCP) and wrist joints were more frequent in men (3).  
Studies using clinical or self-reported OA criteria show lower prevalence estimates of hand 
OA than studies using radiographic definitions (27, 28). A Norwegian population-based 
study found that the prevalence of self-reported hand OA was 4% (28). 
Few studies have described the epidemiology of erosive hand OA in the general population 
(3, 29, 30). The age-standardised prevalence of erosive hand OA was much higher in 
women than in men in the Framingham OA study (10% vs. 3%), and it was especially 
frequent in women 60 years of age or older (3). 
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1.1.3 Pathogenesis 
OA was previously considered as a degenerative cartilage disease but is now recognised to 
involve the whole joint, including the subchondral bone, synovium, capsule, ligaments and 
menisci (if present) (31). We have limited knowledge about the pathogenesis of hand OA, 
and this section will therefore mainly present studies performed in knee OA.  
OA in early stages is a dynamic process with catabolic and anabolic activities, and it is 
characterised by increased chondrocyte proliferation and an up-regulation of the synthetic 
activity in the extracellular matrix of the cartilage. Growth factors and bone morphogenetic 
proteins stimulate the repair of cartilage and the formation of osteophytes. The demand 
subsequently surpasses the capacity of repair. Abnormal mechanical loading and synovial 
inflammation contribute to dysregulation of the chondrocytes and an imbalance in favour of 
increased catabolic activity in the cartilage with gradual loss of proteoglycans and collagen 
type II. These changes are accompanied by fibrillation of the cartilage surface and localised 
production of fibrocartilage. Degradation will result in less ability to withstand normal 
biomechanical stresses, creating a vicious cycle of cartilage damage (32).  
The periarticular bone plays an important role in the OA pathogenesis and can be separated 
into the subchondral bone plate (cortical bone), subchondral trabecular bone and bone at the 
joint margins. The bone alterations in OA reflect bone remodelling and repair processes. 
OA is characterised by increased thickness of the subchondral plate, modified architecture 
of the trabecular bone (thickening and increased number of trabeculae), development of 
subchondral cysts and osteophyte formation at the joint margins (33). Subchondral erosions 
in hand OA seem to be associated with biomechanical loading (reflected as cartilage loss) 
and may possibly be a result of the remodelling process (34). Similarly, the cysts may either 
represent intrusion of joint fluid into the bone by fissurated cartilage (35) and/or be 
consequences of repair of bone destruction (36, 37). Osteophytes are formed at the joint 
margins by proliferation of periosteal and synovial cells, which subsequently differentiate 
into chondrocytes that undergo hypertrophy and endochondral ossification (32, 38).  
Synovitis in OA is assumed to be secondary to cartilage breakdown. Degradation products 
are released into the synovial fluid and get phagocytosed by the synovial cells, which 
produce catabolic and pro-inflammatory mediators. Hence, the production of proteins 
responsible for cartilage breakdown is enhanced, creating a positive feedback loop (39). 
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1.1.4 Risk factors 
Hand OA is caused by a combination of systemic risk factors and local biomechanical 
factors (Figure 1).  
 
Figure 1. Risk factors for development of hand OA, modified from Hunter DJ (40). 
 
The prevalence and incidence of hand OA increase with age (3), which is probably due to a 
cumulative exposure to various risk factors and biologic changes related to aging. 
Epidemiological studies have shown that hand OA is more common in women than in men 
after the age of menopause (3), but the relationship between sexual hormones and OA is 
controversial. Most evidence points in the direction of no relation between female hormonal 
aspects and OA in the hand, hip and knee joints, but the results are conflicting (41).  
The genetic influence in hand OA has been estimated to be approximately 30-60% (42, 43). 
OA is genetically heterogeneous with multiple genes contributing to small increases in the 
overall risk of OA. Candidate gene studies and genome-wide association studies have 
revealed polymorphisms and mutations in genes in control of skeletal development, genes 
encoding extracellular matrix proteins and signal proteins related to inflammation (44-46). 
Obesity has been discovered as a risk factor for hand OA, suggesting that the link between 
obesity and OA is not only mediated through biomechanical loading (47, 48). Recent 
studies have suggested that metabolic factors associated with obesity alter the systemic 
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levels of pro-inflammatory cytokines, which are also related to OA. However, clinical 
studies have shown inconsistent results regarding the association between metabolic factors 
related to obesity and hand OA (49-52). A link between hand OA and cardiovascular 
disease has recently been discovered (20, 53), but the mechanisms behind this association 
are not fully understood and need further investigation.  
The association between bone mineral density (BMD) and hand OA varies across studies 
(54-56). Most clinical data suggest an inverse relationship between OA and osteoporosis, 
but low bone mass may also have a negative effect on the joint cartilage homeostasis (57). 
Biomechanical factors are important in hand OA and not only knee and hip OA. However, it 
is more appropriate to consider the finger joints as load-bearing rather than weight-bearing. 
Most of the intra-articular force in the finger joints is due to contraction of muscles that 
traverse the joints rather than direct loading (58). The DIP joints sustain the highest pressure 
per area during precision grip with contraction of m. flexor profundus, whereas the more 
proximal joints such as the PIP and MCP joints experience the highest pressure during 
power grip when contraction of m. flexor superficialis plays a larger role (58). Manual 
occupation and extensive use of the hands have been associated with hand OA (59-62). 
Clinical studies have suggested that extensive use of precision grip may increase the risk of 
OA in the DIP joints, while extensive use of forceful gripping may lead to OA in the MCP 
joints (62-64). However, there are conflicting results regarding handedness and hand OA 
development (65-67), and the balance between use and overuse is not yet known.  
Hypermobility and subluxation are proven risk factors for thumb base OA (68, 69), while 
hypermobility is shown to protect against OA in the PIP joints (70, 71).  
1.1.5 Management 
The European League Against Rheumatism (EULAR), ACR and Osteoarthritis Research 
Society International (OARSI) have published guidelines and recommendations for the 
management of OA (72-75). However, only EULAR has specific recommendations for 
hand OA (76). Both non-pharmacological and pharmacological treatment are required for 
optimal management of hand OA, and the treatment should be individualised according to 
the localisation of OA, presence of inflammation, levels of symptoms, comorbidities, 
comedication and the patients´ own preferences (76).
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Non-pharmacological therapy 
Non-pharmacological therapy including information, exercise and splints are recommended 
for all patients with hand OA according to the EULAR recommendations (76).  
Pharmacological therapy 
Disease-modifying osteoarthritis drugs (DMOADs) are currently not available (77), and 
pharmacotherapy therefore aims to relieve pain and improve function.  
Local treatments are according to the EULAR recommendations preferred over systemic 
treatments, especially for mild/moderate pain and when few joints are affected (76). 
Paracetamol (acetaminophen) is recommended as first line therapy due to efficacy and 
safety reasons, whereas nonsteroidal antiinflammatory drugs (NSAIDs) should be used if 
inadequate response of paracetamol or if clinical signs of inflammation are present (76). 
Patients who do not respond to oral analgesics may receive intra-articular injections of 
corticosteroids, which is most relevant for the 1st carpometacarpal (CMC) joint (76). 
Opioids and narcotics are indicated only when all other pharmacological options have been 
considered (76).  
Oral glucosamine, chondroitin sulphate, diacerhein, avocado soybean unsaponifiables and 
intra-articular hyaluronan may have a symptomatic benefit (76), but there are few studies 
performed in hand OA. The effect of chondroitin sulphate on structural progression and 
clinical symptoms has been studies in hand OA with limited or conflicting results (78-82). 
A systematic review similarly concluded with minimal effect of chondroitin sulphate in 
knee and hip OA (83). The evidence concerning the effect of intra-articular hyaluronan on 
OA in the 1st CMC joint is sparse, and most studies have been small and not placebo-
controlled (84-87). One controlled study showed no significant differences in pain and 
physical function compared to placebo (88). Anti-inflammatory treatment with a synergistic 
drug of dipyridamole and prednisolone showed a better effect on pain than placebo in hand 
OA (89, 90). Hydroxychloroquine, clodronate (bisphosponate) and monoclonal antibodies 
against interleukin-1 and tumour necrosis factor-α have also been tested in erosive hand 
OA, but the results regarding the effect on structural progression and clinical symptoms are 
limited and conflicting (91-96). Treatment with Vitamin K showed no structural effect (97). 
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To date, no trials have studied the effect of oral glucosamine, diacerhein, avocado soybean 
unsaponifiables, calcitonin or tetracycline in hand OA. Studies have mainly been performed 
in knee OA, and none have so far been approved as a DMOAD due to limited/conflicting 
results or small effect sizes (77). Several trials on the effect of other potential DMOADs are 
ongoing (98), but these studies will not be discussed in this thesis. 
Surgery 
Surgery (trapezioectomy alone or with synthetic/biologic interpositions, osteotomy, 
arthrodesis, total joint replacement) is effective in severe thumb base OA and should be 
considered in patients with severe symptoms when conservative treatments have failed (76). 
 
1.2 The OMERACT filter for outcome measures in Rheumatology 
OMERACT was originally an acronym for “Outcome Measures in Rheumatoid Arthritis 
Clinical Trials” but was later broadened to stand for “Outcome Measures in 
Rheumatology”. It has been an international meeting for professionals interested in outcome 
measures in rheumatology since 1992. The aim of OMERACT is to improve outcome 
measures in rheumatology through a data-driven, iterative consensus process, and the 
guidelines are forever “preliminary” based on the assumption that future data will lead to 
further refinement and modification of the guidelines. The selection of valid domains 
follows the guidelines formulated by Bombardier and Tugwell (99-102) and re-formulated 
into the “OMERACT filter” (103). The filter can be summarised into three domains, of 
which each represents a question to be answered of the outcome measure (Table 2). An 
outcome measure is valid for use if it can answer all three questions. 
The OMERACT process inspired the work in this thesis. We have focused on aspects from 
the first and second domains; the construct validity and reliability of MRI in hand OA.  
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Table 2. The OMERACT filter (103). 
Domain Question Content 
Truth Is the measure truthful, unbiased 
and does it measure what is 
intended? 
This concept captures issues of face, 
content, construct and criterion 
validity. 
Discrimination Does the measure discriminate 
between situations of interest? 
This concept captures issues of 
reliability and sensitivity to change, 
either for states at one time (for 
classification/prognosis) or states at 
different times (to measure change).  
Feasibility Can the measure be applied 
easily, given constraints of time, 
money and interpretability? 
This concept captures the practical 
extent to which an outcome measure 
can be applied successfully.  
 
Validity of MRI includes different aspects concerning whether MRI is measuring what it 
intends to measure (104, 105). Good face validity requires that the outcome measure is 
generally viewed as relevant and useful based on the current knowledge. Content validity 
refers to whether the outcome measure is covering all the areas of relevance (in this thesis: 
both relevant OA features and anatomical coverage), while construct validity refers to 
whether the outcome measure makes biological sense and whether it is consistent with other 
measures. Criterion validity is the degree to which the outcome measure truly reflects a gold 
standard. In this thesis, we focused on the construct validity of MRI against conventional 
radiography (CR) (paper II) and measures of pain and physical function (paper III).  
Reliability refers to the consistency of the measurement, i.e., the degree to which an 
instrument measures the same at two separate times. In this thesis, both the same observer 
and different observers re-evaluated the MRI scans (blinded for the first measurement) in 
order to make repeated measurements, and the intra-observer and inter-observer reliability 
could be calculated respectively (paper I). Sensitivity to change was not examined due to 
only cross-sectional MRI data.  
The 3rd aspect of the OMERACT filter, i.e., the feasibility of the proposed MRI scoring 
system in hand OA (paper I), will be briefly discussed.  
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1.3 Clinical assessment of hand OA 
1.3.1 Clinical joint examination 
Physical examination is needed to confirm and characterise joint involvement and to 
exclude differential diagnoses such as rheumatoid arthritis (RA) and psoriatic arthritis 
(PsA). Clinical joint examination includes assessment of bony enlargement, soft tissue 
swelling, tenderness and limited motion.  
Heberden’s and Bouchard’s nodes are firm swellings over the lateral or dorsal aspects of the 
DIP and PIP joints respectively (106). These nodes are associated (but not synonymous) 
with underlying radiographic changes of OA and especially osteophytes (107, 108). Bony 
enlargement can be difficult to distinguish from joint effusion. It has been suggested that the 
lateral nodes are occurring in area with the least resistance in the capsule, such as between 
the extensor tendon and the collateral ligaments (106, 109, 110), while the dorsal nodes 
represent traction spurs. The lateral and dorsal nodes may also coexist and fuse (106). 
1.3.2 Patient-reported outcomes 
Patients with hand OA suffer from joint pain, swelling, stiffness, limited motion and 
deformity, resulting in poorer health-related quality of life (2). They describe problems 
within many domains of activity and participation, and tasks requiring considerable grip 
strength combined with twisting of the hands represent the most frequently described hand 
related problems (111). The International Classification of Functioning, Disability and 
Health (ICF) by the World Health Organisation offers a comprehensive understanding of 
functioning, which is described as a complex interplay between body functions and 
structures, activities, participation and contextual factors (112). 
The OMERACT initiative has recommended pain, physical function and patient global 
assessment as the three core domains in hand OA (113). However, there is no consensus 
about the preferred instrument (114). Several disease-specific instruments have been 
designed for hand OA, such as the Australian Canadian (AUSCAN) hand index (115), the 
Score for Assessment and quantification of Chronic Rheumatoid Affections of the Hands 
(SACRAH) (116), the Cochin Hand Functional Disability Scale (117) and the Functional 
Index of Hand OA (FIHOA) (118). The AUSCAN and SACRAH comprise pain, stiffness 
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and physical function, while the FIHOA and Cochin comprise physical function only. The 
Arthritis Impact Measurement Scales-2 (AIMS-2), which is an arthritis-specific instrument, 
has also a subscale of hand and finger function (119). The instruments have been translated, 
and the Norwegian versions of AUSCAN, FIHOA and AIMS-2 have shown satisfactory 
psychometric properties (120-123). Levels of “Patient-Acceptable Symptom State” (PASS) 
for AUSCAN pain (below 8.2 on a 0-20 scale) and AUSCAN physical function (below 16.1 
on a 0-36 scale) have been proposed (124).  
Joint pain can also be measured on visual analogue scales (0-100 mm). 
1.3.3 Objective measures of physical function 
Measurement of grip strength is a surrogate marker of impairment in hand OA and can be 
measured by a hand dynamometer (e.g., JAMAR) (125).  
The fine motor dexterity of the hand can be measured with Moberg Pick-up test. The 
patients are instructed to pick up twelve items one at a time and place them into a container 
as fast as possible, and the performance is timed with a stop watch (126).  
 
1.4 Magnetic resonance imaging (MRI) in OA 
1.4.1 Principles of MRI 
A detailed description of the theoretical basis of MRI physics is beyond the scope of this 
thesis. The following sections will give a brief introduction of the principles and technical 
aspects of MRI (127, 128).  
MRI is based on the electromagnetic properties of the atomic nuclei. The hydrogen nuclei (1 
proton, 0 neutron) are most often used in clinical MRI due to the abundance in the human 
body. The hydrogen nuclei spin around their own axis, inducing a magnetic field around 
each nucleus. The magnetic moments have a size and a direction (i.e., a vector), but they 
will be randomly orientated in the absence of an external magnetic field (B0). When the 
nuclei are exposed to B0, the magnetic moments of the nuclei will align with B0 in parallel 
or anti-parallel direction, creating a net magnetisation vector. B0 also causes the nuclei to 
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spin around the axis of B0, which is called precession. The hydrogen nuclei have a 
precessional frequency that is different from other MRI active nuclei, and this allows 
specific imaging of hydrogen nuclei in the body.  
The hydrogen nuclei gain energy from resonance, which is the phenomenon that occurs 
when the nuclei are exposed to an oscillation that is close to their natural precessional 
frequency. Application of a radiofrequency (RF) pulse leads to excitation of the hydrogen 
nuclei in parallel position to B0 into anti-parallel position or into the transversal plane by a 
certain angle (i.e., flip angle). The hydrogen nuclei also move into the same phase. This 
coherent moving of magnetisation in the transverse plane produces magnetic field 
fluctuations and an electrical voltage in the receiver coil. This electrical voltage constitutes 
the MRI signal.  
When the RF pulse is switched off, the net magnetisation vector will again be influenced by 
B0 and will try to align with it. The nuclei must lose the energy that was previously gained 
by the RF pulse in a process called relaxation. Recovery is the regain of magnetisation in 
the longitudinal plane, while decay is the loss of magnetisation in the transversal plane. 
1.4.2 Technical aspects of MRI 
The MRI unit 
The main components of an MRI unit are the following (127, 128):  
1. The main magnet, which produces B0. The strength of B0 is important for image quality 
(higher strength increases signal-to-noise ratio and gives higher resolution) and feasibility 
(higher strength gives less scanning time).  
2. The gradient coils, which provide the exact location and amplitude of the signal. 
Gradients are alterations to the magnetic field that are generated by coils of wire located 
within the bore of the magnet along the longitudinal, vertical and horizontal axes.  
3. The RF transmission system, which provides excitation of the hydrogen nuclei. It consists 
of a radiofrequency sender and receiver.  
4. The data processing system for image acquisition. The raw imaging data is stored in the 
MRI system and must be transformed to obtain the final images.  
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MR pulse sequences 
Spin echo (SE) and gradient echo (GRE) sequences represent two fundamental types of 
MRI pulse sequences (128). The pulse sequences can also be either two-dimensional (2D) 
with one plane acquired at a time or three-dimensional (3D) with imaging of an entire 
volume in one acquisition. The 3D images can be manipulated to look at the anatomy in any 
plane and at any angle of obliquity.  
In SE sequences, an initial RF pulse directs the net magnetisation vector into the transverse 
plane (i.e., the flip angle is always 90 degrees). A second RF pulse with a flip angle of 180 
degrees is then applied to rephase the spinning nuclei. In this thesis, we used a 2D Short Tau 
Inversion Recovery (STIR) sequence, which is a SE sequence variant with a 180 degrees 
preparatory pulse in order to null the signal from fat (128).  
In GRE sequences, the flip angle is variable (15-75 degrees) and the net magnetisation 
vector will partly be flipped into the transverse plane. Gradients instead of RF pulses are 
used to dephase and rephase the transverse magnetisation. In this thesis, we used a 3D 
Dixon technique.  
The STIR and Dixon techniques are described in more detail in the next sections.  
Image quality 
The image quality is mainly dependent of contrasts, resolution and noise/artefacts (127, 
128): 
1. Contrast 
Contrast refers to the difference in signal intensities between two regions of an MRI scan. 
Factors that affect image contrasts are usually divided into intrinsic and extrinsic contrast 
parameters.  
Intrinsic contrast parameters are inherent to the body’s tissue and cannot be changed. 
Images obtain contrast mainly through mechanisms of T1 recovery, T2 decay, T2* (T2 star) 
decay and proton density (PD). During T1 recovery (“spin-lattice”), the nuclei are getting 
realigned with B0 due to release of energy from the spinning nuclei to the environment. 
Time 1 (T1) is the time in milliseconds required for 63% of the nuclei to realign with B0. 
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During T2 decay (“spin-spin”) and T2* decay, the nuclei are dephased due to interaction 
between the spinning nuclei and magnetic field inhomogeneities respectively. Time 2 (T2) 
is the time in milliseconds when the magnetisation in the transverse plane has lost 63% of 
its original value. PD is a measure of proton concentration, i.e., the number of atomic nuclei 
per given volume. Water and fat represents two extremes of MRI contrast with different T1 
and T2 times.  
The inherent T1, T2 and PD mechanisms occur simultaneously in any image, but one 
process can be made dominant by external contrast parameters. The most important 
parameters are repetition time (TR), echo time (TE) and flip angle, which all can be selected 
at the operator console. The TR time is time interval between the beginnings of two 
successive series of RF pulses, and it controls the extent of T1 recovery before a new serie 
of RF pulses is applied. The TE time is the interval between the centre of the RF pulse and 
the centre of the recorded echo, and it controls the amount of T2 decay before the signal is 
received.  
In T1-weighted images, the T1 contrast is accentuated by a short TR interval. Tissue with 
long T1 (e.g., water) will not be able to recover and align with B0. Water has less 
longitudinal magnetisation than fat before the next RF pulse and therefore less transverse 
magnetisation after the RF pulse. Hence, water will appear dark compared to tissues with 
short T1 (e.g., fat). TE is short in order to limit the T2-weighting.  
In T2-weighted images, a long TE interval is used to accentuate the inherent differences in 
T2 between different tissues. Tissues with long T2 (e.g., water) will take longer to decay 
and will have greater signal and appear brighter than signal with short T2 (e.g., fat). TR 
value is long in order to limit the T1-weighting.  
With PD-weighting, the numbers of protons per unit volume is the main determinant for 
image contrast. The effects of T1 and T2 contrast must be diminished by long TR and short 
TE values to achieve PD-weighting.  
The fat signal will occur bright in many important clinical imaging sequences and can 
obscure underlying pathology such as inflammation and oedema (129). Hence, in many 
situations it is useful to null the signal from fat. This can be done by several methods such 
as chemical shift selective saturation, out-of-phase imaging (Dixon technique) and STIR 
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sequences. We will here briefly explain the mechanisms of fat saturation by the Dixon 
technique and the STIR sequence, which were used in the current thesis.  
The Dixon technique is used in GRE sequences to null the signal from voxels (i.e., pixel 
volumes) in which fat and water coexist. Fat and water have different precessional 
frequencies and can therefore be imaged when they are in the same phase at certain time 
points and when they are at different phases at other time points. By adding and subtracting 
the “in-phase” and “out-of-phase” images, water and fat images can be separated (130, 131). 
The technique allows fast acquisition of T1-weighted images (131).  
STIR is an inversion recovery pulse that uses the inversion time (TI, tau), which is the time 
it takes for fat to recover from full inversion (180 degrees) to the transverse plane (90 
degrees) so that there is no longitudinal magnetisation of fat (null point). The conventional 
90 degrees RF pulse will flip the fat vector back to 180 degrees inversion, so there is no 
transverse component of fat after excitation. Hence, no signal will be produced from fat 
whereas water will still produce signal. Several 180 degrees pulses can then be applied in 
order to amplify the signal from water. Practically STIR is only used with fast SE or SE 
techniques. T2 and T1 differences contribute additively to the contrast in STIR sequences, 
and the contrast is therefore very good and tissues with long T1 and long T2 appear very 
bright (127, 129). 
2. Resolution 
The spatial resolution is the ability to distinguish between two points as separate and 
distinct. The resolution is controlled by the voxel size, which is a volume of tissue within 
the patient determined by the pixel area and slice thickness. The pixel area is determined by 
the size of the field of view (FOV) and the number of pixels in the FOV (i.e., matrix). The 
spatial resolution is higher when the voxels are small. However, small voxels contain less 
nuclei that contribute to the signal and will therefore have lower signal-to-noise ratio (127).  
3. Noise and artefacts 
Signal-to-noise ratio is defined as the ratio between a signal (i.e., meaningful information) 
and the background noise (i.e., unwanted signal generated by the patient in the magnet and 
the background electrical noise of the system). It should be as high as possible and is 
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achieved by a coarse (not fine) matrix, thick slices and high field strength as well as 
specialised coils.  
Artefacts represent undesired image distortions, which can lead to misinterpretations of 
MRI data. Pitfalls in scoring of MRI scans of the wrist and MCP joints in RA have been 
described (132), and many of the same considerations are applicable in hand OA. The 
following sections will describe the artefacts that are most relevant in the current thesis: 
Partial volume artefacts occur when a structure is only partly contained within the voxel, 
and they are most marked in regions where tissues of different signal intensity adjoin (e.g., 
the interface between inflamed synovial membrane and bone). Inhomogeneity of fat 
suppression may occur when the area being imaged lies within a part of B0 that is not 
completely uniform. Both partial volume artefacts and inhomogeneous fat suppression may 
result in an appearance mimicking bone marrow lesions (BMLs).  
Susceptibility artefacts can occur when adjacent tissues have different susceptibilities, 
which is the degree of magnetisation by B0. A wide range of precessional frequencies can 
appear within a voxel, which can cancel each other out. Metal artefact is an example of a 
severe susceptibility artefact.  
The “magic-angle” phenomenon refers to the increase in signal intensity that occurs when 
collagen fibres are oriented at 55 degrees relative to B0. Collagen fibres restrict the mobility 
of water protons and promote interactions between the nuclei, contributing to T2 decay and 
low signal intensity. The extent of the “spin-spin” interactions varies according to the angle 
of the fibres in relation to the axis of B0 and is minimal at an angle of 55° (i.e., maximal T2 
time). Hence, the signal intensity of the collagen fibres with this specific angle in relation to 
B0 will be increased. This artefact affects any collagen-containing structures, including 
articular cartilage, menisci and ligaments (of which the latter is relevant in this thesis), and 
it can mimic tissue damage or reduce contrast towards adjacent structures (133). 
Other artefacts include chemical shift artefacts, truncation artefacts, wrap-around artefacts, 
movement artefacts and pulsation artefacts, which will not be explained in further detail 
(132).  
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1.4.3 Advantages and limitations of MRI 
MRI allows the joint to be visualised as a whole organ and provides much more detailed 
picture of the OA changes than any other imaging modality without any radiation. MRI has 
unlimited image contrast possibilities, and contrast-enhanced imaging provides additional 
information about synovitis (134).  
Disadvantages of MRI include the high price compared with CR, long acquisition time and 
contraindications to the procedure. MRI is contraindicated in patients with aneurysm clips, 
pacemakers, cochlear implant and metallic splinters in the eye. The MRI equipment is 
expensive to purchase, maintain and operate. Experts are needed for input on the selection 
of sequences and correct utilisation, and the readers must be aware of artefacts during the 
interpretation of images (134, 135). 
Gadolinium (Gd) contrast may lead to nephrogenic systemic fibrosis and should not be 
administrated to persons with reduced kidney function (136). It typically manifests with 
skin tightening, tethering and hyperpigmentation, and systemic fibrosis of internal organs 
has been identified due to deposition of free Gd in the tissues (136).  
1.4.4 Assessment of OA pathologies with MRI 
Cartilage morphology and composition 
MRI of the cartilage can be classified into morphological (structural) and compositional 
assessment (137).  
The cartilage morphology can be evaluated by semi-quantitative or quantitative methods. 
Focal cartilage defects are best visualised by either direct MRI arthrography (intra-articular 
contrast) or indirect arthrography (intravenous contrast with delayed imaging so the contrast 
can diffuse into the synovial fluid). Other good alternatives are fluid-sensitive sequences 
(fat-saturated PD-weighted and T2-weighted fast SE sequences), which give an 
arthrographic effect of the cartilage (low signal intensity) against the synovial fluid (high 
signal intensity). Conventional T1-weighted SE images offer poor contrast between 
cartilage and fluid. GRE imaging with fat-saturation, which was used in the current thesis, 
provides the highest contrast between cartilage (high signal intensity) and bone (low signal 
intensity) but less contrast between the cartilage and the adjacent synovial fluid. GRE 
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sequences are therefore less suitable for assessment of focal cartilage defects, but they are 
frequently used in knee OA for quantitative assessment of cartilage volume and thickness 
due to the high spatial resolution (134).  
Compositional assessment of cartilage includes techniques such as T2 mapping, T1rho, 
delayed Gd-enhanced MRI of Cartilage (dGEMRIC), sodium imaging and diffusion-
weighted imaging (137). These techniques allow biochemical or molecular imaging of the 
cartilage and may detect “pre-morphological” cartilage changes (138-140). These 
techniques are not part of the current thesis and will not be further explained.  
Synovitis 
MRI can visualise synovitis, either with or without the use of Gd contrast. Gd contrast has 
been recommended for optimal assessment of synovitis in knee OA and RA (141, 142). Use 
of contrast promotes the distinction between synovial effusion and synovial tissue, but 
diffusion of contrast from the synovial membrane to the synovial fluid obscures the 
boundary between these two components.  
Synovitis is usually evaluated by semi-quantitative scoring methods (as described later), but 
quantification of synovitis can also be performed by semi-automated volume analyses (143) 
or dynamic contrast-enhanced MRI (144, 145).  
Bone morphology 
Cysts are seen as well-defined areas with fluid-like signal intensity on unenhanced MRI 
scans. Most subchondral cysts show post-Gd enhancement, which may be due to entering of 
synovial fluid or tissue through chondral fissures and/or diffusion of contrast into the cysts 
from surrounding areas with bone remodelling (37).  
OA-related BMLs are seen as hyperintense areas often with diffuse borders. Optimal 
assessment can be achieved by either a fat-saturated T2-weighted, PD-weighted or a STIR 
sequence (134). Histological studies in knee OA have shown that BMLs mainly contain 
necrosis, fibrosis, remodelled trabeculae and only minimal oedema (146). The mineral 
content in these lesions is reduced due to remodelling with high bone turn-over (147).  
Bone attrition in the knee is seen as flattening or depression of the joint plate (148), which is 
probably caused by bone remodelling (149). Erosions in the finger joints may have a similar 
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appearance with typical “seagull wing” configuration, but the erosions can also be located at 
the joint margins (150).  
Cortical bone produces a signal void on MRI. The imaging of osteophytes is therefore 
dependent on good contrast towards the adjacent tissues.  
Ligaments and tendons 
Foci of high signal intensity due to the “magic angle” phenomenon on MRI scans may 
mimic inflammation and tear (133).  
1.4.5 MRI scoring systems in knee and hip OA 
To date, four semi-quantitative MRI scoring systems for knee OA have been published: The 
Whole Organ MRI scoring system (WORMS), Knee Osteoarthritis Scoring System (KOSS), 
Boston Leeds Osteoarthritis Knee Score (BLOKS) and MRI Osteoarthritis Knee Score 
(MOAKS) (151-154). They include a variety of OA features that are believed to be relevant 
to pain and functional integrity of the joint and/or the pathophysiological processes. The 
details of the different scoring systems will not be explained in detail in this thesis. The 
WORMS is most commonly used and includes the following features: Cartilage, BMLs, 
cysts, osteophytes, attrition, meniscal status, combined effusion/synovitis, collateral/cruciate 
ligaments and periarticular features (151). KOSS and BLOKS cover mostly the same 
features but differ with respect to the grading and the use of a lesion-orientated approach 
rather than a strict subregional approach (152, 153). The process behind the development of 
the scoring system was only described for the BLOKS (153). Excellent reliability data has 
been published for WORMS, KOSS and BLOKS (155). However, limitations of the scoring 
systems have been revealed, and the MOAKS was therefore just recently evolved (154). 
Furthermore, a separate scoring system for assessment of contrast-enhanced synovitis in 
knee OA was recently proposed, showing good reliability and validity against patient-
reported pain (156).  
The Hip OA MRI scoring system (HOAMS) was recently presented (157). The scoring 
system is extensive and includes features such as cartilage, BMLs, subchondral cysts, 
osteophytes, labral lesions, synovitis, effusion, loose bodies, attrition, dysplasia, greater 
trochanter tendonitis/bursitis, labral hypertrophy, paralabral cysts and herniation pits. Good 
reliability was found for most features. The authors did not describe the process behind the 
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development of the scoring system but emphasised that the current study was only the initial 
step in the development of an MRI scoring system for hip OA. Further validation, 
assessment of responsiveness and refinement of the scoring system are needed (157). 
1.4.6 MRI scoring systems in inflammatory arthritic diseases 
The OMERACT RA MRI score (RAMRIS) and PsA MRI score (PsAMRIS) have 
facilitated the use of MRI for assessment of pathology in RA and PsA respectively. The 
scoring systems were developed by similar processes by a group of experts (mainly 
radiologists and rheumatologists) under the umbrella of OMERACT. The processes have 
included agreement upon definitions, scoring exercises and eventual possible modifications 
of the scoring systems.  
The RAMRIS consists of a core set of MRI sequences as well as definitions and a semi-
quantitative scoring system for erosions, bone marrow oedema and synovitis located in the 
wrist and MCP joints. The core set of sequences should include MRI scans in 2 planes with 
T1-weighted images pre- and post-Gd for assessment of synovitis (grade 0-3) and erosions 
(grade 0-10) in addition to a T2-weighted fat-saturated sequence or a STIR sequence for 
assessment of bone marrow oedema (grade 0-3) (158). Furthermore, the OMERACT group 
has in collaboration with EULAR developed an atlas with reference images in RA joints 
(159, 160). Several exercises have been performed with good intra- and inter-reader 
reliability for both cross-sectional and longitudinal readings (104, 161).  
The PsAMRIS similarly consists of a core set of MRI sequences as well as definitions and a 
semi-quantitative scoring system for erosions (grade 0-10), bone marrow oedema (grade 0-
3), synovitis (grade 0-3), flexor tenosynovitis (grade 0-3), periarticular inflammation (grade 
0-1) and bone proliferation (grade 0-1) located in the MCP, PIP and DIP joints (162). The 
core set of MRI sequences was the same as reported for RAMRIS. The definitions of the 
features are presented in table 3. Bone oedema, erosions and bone proliferations were 
assessed in the distal and proximal part of the joint separately, and the assessed area 
extended from the surface to the middle of the phalanx. The scoring system has shown good 
intra- and inter-reader reliability for both cross-sectional and longitudinal readings (163).  
 28 
Table 3. The definitions of features in PsAMRIS (162).  
Feature Definition 
Synovitis An area in the synovial compartment that shows post-Gd enhancement of a 
thickness greater than the width of normal synovium. 
Flexor 
tenosynovitis 
Signal characteristics consistent with increased water content (i.e., high 
signal intensity on T2-weighted fat-saturated and STIR images, and low 
signal on T1-weighted images) or abnormal post-Gd enhancement adjacent 
to a tendon in an area with a tendon sheath.  
Periarticular 
inflammation 
Signal characteristics consistent with increased water content (i.e., high 
signal on T2-weighted fat-saturated and STIR images) or abnormal post-Gd 
enhancement at extra-articular sites including the periosteum and the 
entheses but not the tendon sheaths. 
Bone 
marrow 
oedema 
A lesion within the trabecular bone with signal characteristics consistent 
with increased water content (i.e., high signal intensity on T2-weighted fat-
saturated or STIR images, low signal intensity on T1-weighted images) and 
often with ill-defined margins.  
Bone erosion A sharply marginated bone lesion with typical signal characteristics (i.e., 
loss of normal low signal intensity of cortical bone and normal high signal 
intensity of marrow fat on T1-weighted images), which are visible in two 
planes with a cortical break seen in at least one plane.  
Bone 
proliferation 
Abnormal bone formation in the periarticular region, such as at the 
entheses and across the joints.  
Gd = gadolinium, STIR = Short Tau Inversion Recovery. 
 
1.5 Conventional radiography (CR) in OA 
1.5.1 Principles of CR 
Radiography is the use of X-rays, which is a form of electromagnetic radiation with a wave-
length in the range of 0.01 to 10 nanometres. The basic principles and interpretation of CR 
have remained essentially the same since the first discovery by Röntgen in 1895. An X-ray 
tube consists of two principle elements; a cathode and an anode. The cathode terminal is a 
tungsten alloy filament, which is heated to produce a stream of electrons. When high 
voltage is applied across the two terminals, the electrons are attracted towards the anode. X-
rays are produced when they hit the tungsten target.  
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Due to the short wavelength, X-rays can penetrate materials that do not transmit visible 
light. The X-rays are projected towards an object, which will absorb a variable proportion of 
the X-rays depending on its density and composition. A detector (either analogue films 
sensitive to X-rays or digital detectors) captures the X-rays that pass through the object, 
leading to a 2D presentation of all the structures superimposed on each other. Dense 
structures that block the passage of the X-ray beam through the body, such as bones, appear 
white. Softer body tissues such as the skin and muscles allow the X-rays to pass through and 
appear darker (164, 165).  
1.5.2 Technical aspects of CR 
The X-ray generating system has three major components; the operating console, the X-ray 
tube (where X-rays are produced) and the generator (where electricity is transformed and 
rectified) (165).  
X-rays cause blackening of the emulsion of a photographic film (165). Norwegian hospitals 
have the recent years converted from film-based to digital radiography, which consist of a 
digital detector instead of the analogue films and cassettes. The detector absorbs the energy 
carried by the X-rays, which is then transformed into electrical charges that are digitised and 
in a proportional manner quantified into a grey-scale image (166). The advantages of digital 
imaging include elimination of chemical processing of films, reduced space requirements 
for storage, adjustment using dedicated computer software to optimise image quality and 
rapid transmission of images to other locations.  
Projections are described by the direction of the X-ray beam. The posteroanterior view (i.e., 
beam in dorsal to palmar direction) of the hands is always provided in both research and 
clinical settings. However, oblique and/or lateral views may provide additional information. 
Accurate interpretation of the radiographs depends on appropriate positioning of the hands 
(the hands should be opened, pronated and placed flat against the cassette) and appropriate 
film exposure. The exposure is determined by the ability of the beam to penetrate an object 
(controlled by voltage adjustment) and the number of X-rays photons (“light particles”) in 
the beam (milliampere per second) (165). 
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1.5.3 Advantages and limitations of CR 
Plain radiography is the “gold standard” for imaging of OA joints. The method is 
inexpensive, fast, easily available and provides a good picture of bony changes such as 
osteophytes (located on the medial and lateral side of the joint), sclerosis, osteoporosis and 
soft tissue calcifications.  
CR is limited by radiation exposure, but the dose of radiation for hand radiography is 
minimal (0.001 millisievert, which corresponds to only 3 hours of natural background 
radiation). The main limitation of radiography is its inability to directly visualise cartilage, 
synovitis, other non-osseous structures and BMLs. Reproducibility of positioning and joint 
alignment may be problematic for CR of the knees, but is less controversial for hand 
radiography (134, 135). 
1.5.4 Assessment of OA pathologies with CR 
CR provides a 2D picture of bony changes, such as osteophytes, erosions, cysts and 
sclerosis. Cartilage, synovium, synovial fluid and capsule have the same radiodensity as the 
surrounding soft tissues, and these structures cannot be visualised directly (165). Hence, 
radiographic joint space narrowing (JSN) is only an indirect measure of cartilage loss. 
Osteophytes are seen as bony protrusions at the joint margins of the finger joints. The “true” 
intra-articular osteophytes are best visualised on CR with posteroanterior view. Traction 
spurs that develop at the dorsal side of the DIP and PIP joints as a physiological response at 
the insertion site of the extensor tendon can easily be seen on CR with lateral or oblique 
view (167). In this thesis, only the posteroanterior images were assessed.  
Erosive hand OA is characterised by bone damage in the central part of the DIP and PIP 
joints and less frequently the thumb base (3, 29). They typically have “seagull wing” or 
“saw-tooth” patterns. Erosions located at the joint margins are less commonly seen on CR 
(150). Dorsal or plantar erosions can be recognised when they are seen in profile, but can be 
confused with cysts on frontal images. Subchondral cysts are seen as well-defined areas 
with loss of the trabecular bone structure. Sclerosis is seen as increased brightness of the 
subchondral bone on CR and represents increased thickness of the subchondral cortical plate 
and the subjacent horizontal trabeculae (168).  
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Radiographic JSN is still the only structural endpoint that is accepted by regulatory bodies 
in the United States (Food and Drug Administration) and Europe (European Medicines 
Agency) to prove efficacy of DMOADs in phase III clinical trials (169). JSN in hand OA 
can be measured on semi-quantitative scales or quantitatively with use of automated or 
semi-automated methods (170-173).  
1.5.5 Radiographic scoring systems in hand OA 
Several scoring systems for assessment of radiographic hand OA have been developed 
(174), and the most widely used systems will be presented in the following sections. The 
scales differ in assessed joints and whether they provide a global estimation of OA or 
evaluate individual OA features. Currently, there is no consensus on the preferred scale.  
The Kellgren and Lawrence (KL) scale from 1957 was the first proposed radiographic 
scoring system (13) and is still most widely used (15). KL is a global scale, which grades 
OA on a 0-4 scale (of which grade ≥ 2 represents definite OA) based on the 
presence/severity of osteophytes/ossicles, JSN, sclerosis, pseudocystic areas and altered 
shape of bone ends (13). The World Health Organisation adopted the scale in 1961 as the 
“gold standard” for assessment of OA, and in 1963 the authors published an atlas with 
radiographic example images and legends describing the features in each particular film 
(14). The written definitions of the grades vary across joint groups, and these descriptions 
also differ from later written descriptions by Lawrence in 1977 (175). These different 
descriptions across publications have caused confusion in how to interpret the different 
grades. Further, the KL scale has been criticised for too much emphasis on osteophytes 
(176), as narrowed/sclerotic joints cannot be classified as having OA unless osteophytes are 
present. Thus, several studies have used modified KL scales to overcome these limitations.  
Several scoring systems with more detailed assessment of individual hand OA features have 
been developed in order to address the deficiencies of the KL scale and optimise agreement 
(170, 177, 178). Among those, the OARSI atlas from 1995 (revision in 2007) is most 
frequently used (170, 178). With this atlas as reference, the presence/severity of individual 
features such as osteophytes, JSN, subchondral erosions (pseudowidening), cysts, 
subchondral sclerosis and malalignment are assessed on semi-quantitative scales.  
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Other global scales have been proposed with more emphasis on JSN in comparison to the 
KL scale (179, 180). However, none of these proposed indices have been extensively used. 
Verbruggen et al. developed two numerical scoring systems for the progression and 
anatomic evolution of erosive and non-erosive hand OA (17, 181). The anatomical lesion 
progression system assesses changes of osteophytes, JSN and cysts (+/- 0.5 point for 
increase/decrease in size and +/- 1 point for appearance/disappearance) (181). The 
anatomical phase progression system is more frequently used and is based on an assumption 
of hand OA as a disease that undergoes predictable phases; S phase (the joint has classical 
hand OA features with osteophytes, JSN and/or subchondral bone changes), J phase (the 
joint space disappears), E phase (the subchondral plate becomes eroded) and lastly the R 
phase (repair or remodelling of the joint) (17). Recently, Verbruggen et al. also proposed a 
more complex scoring system; the Ghent University Scoring System, which is more 
sensitive for detection of progression during the destructive phases (182). With this scoring 
system, the proportions of normal subchondral bone, subchondral plate and joint space are 
assessed on 0-100 scales with 10 units increase.  
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2. General aims and specific research questions 
2.1 General aims 
The general aims of this thesis were to develop an MRI scoring system in hand OA and to 
study the reliability and validity of structural and inflammatory MRI features.  
 
2.2 Specific research questions 
− What is the intra-reader and inter-reader reliability for status scores of structural and 
inflammatory MRI features in hand OA (paper I)? 
− How prevalent are structural and inflammatory MRI features in a cohort of hand OA 
patients (paper II-III)? 
− What is the prevalence of structural and inflammatory MRI features across joints with 
different radiographic severity (paper II)? 
− What is the agreement between MRI and CR in detection of structural OA features 
(paper II)? 
− What is the sensitivity and specificity of MRI in detection of structural features in 
comparison to CR (paper II)? 
− Are structural and inflammatory MRI features associated with tenderness in the same 
joint (paper III)? 
− Is the amount of structural and inflammatory MRI features associated with patient-
reported pain, functioning and measurement of grip strength (paper III)? 
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3. Material and methods 
3.1 Study designs 
The results in the current thesis are based on data from an observational study with cross-
sectional study design.  
In paper I, we presented an MRI scoring system for hand OA and applied a test-retest 
design in order to calculate the intra-reader and inter-reader reliability of the MRI readings. 
MRI scans of the DIP and PIP joints of the dominant hand from ten hand OA patients (one 
time point) were evaluated independently by three readers and the readings were repeated 
by the same readers after one week.  
We validated the MRI features against radiographic features in paper II and against 
measures of pain and physical function in paper III (all examinations performed at 
approximately same time point).  
 
3.2 Study population 
3.2.1 The Oslo hand OA cohort 
The initiative to the Oslo hand OA cohort started in 2000 with the intention to evaluate 
health-related quality of life in patients with hand OA and to study the prediction of long-
term outcomes. Potential study participants were identified by using diagnostic codes in the 
hospital data system at Department of Rheumatology (Diakonhjemmet Hospital). Men and 
women between 50 and 70 years, who had been examined at the outpatient rheumatology 
clinic within the previous 2 years, were eligible for inclusion in the cohort if they had a 
diagnosis of hand OA and no other rheumatic diseases. In total 275 eligible patients with 
hand OA were identified after a thorough review of the patient records. The patients were 
contacted by postal mail, and 209 of 275 (76%) consented to participate in the data 
collection (questionnaires/interview, clinical examination and CR of both hands).  
The 209 patients were again contacted by postal mail in 2008, and 128 of 209 (61%) met for 
a follow-up examination in the period 2008-2009. Reasons for non-participation at the 
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follow-up examination are shown in figure 2. In total 4 patients were diagnosed with or 
examined for RA or PsA during the period of follow-up, and they were therefore excluded 
from the cohort. The data collection included the same questionnaires and examinations 
(including CR) that were performed at baseline but also ultrasonography (US) of both hands 
and contrast-enhanced MRI of the dominant hand. MRI with T1-weighted pre-Gd and STIR 
images was performed in 107 patients, of whom 97 also had T1-weighted post-Gd images. 
Both CR and MRI were performed in 106 patients. MRI was optimally performed on the 
same day as the clinical examination, and 85 participants had an interval between MRI and 
clinical examination of 22 days or less. Prolonged interval between the examinations was 
mainly due to practical challenges at the Department of Radiology (Diakonhjemmet 
Hospital).  
All patients described in this thesis had clinical and/or radiographic hand OA. The clinical 
ACR criteria were fulfilled by 100 of 107 patients (93%) (12), while 104 of 106 patients 
(98%) had radiographic hand OA defined as one or more joint(s) with KL grade > 2 (13).  
  
Figure 2. Flowchart of the patients in the Oslo hand OA cohort.  
3.2.2 Selection of patients 
The analyses in paper I-III were performed on data from the follow-up examination of the 
Oslo hand OA cohort in 2008-2009.  
In paper I, we performed a reliability exercise using MRI scans from ten patients, who were 
randomly selected among 97 patients with pre-and post-Gd MRI scans. The selection of 
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patients was based on the severity of radiographic hand OA, i.e., the sum score of KL 
grades in the DIP and PIP joints in the hand that was imaged by MRI. We selected two 
patients with available T1-weighted pre- and post-Gd and STIR images from each quintile 
of the radiographic severity scores.  
In paper II, we included 106 patients with available MRI scans (T1-weighted pre-Gd and 
STIR images) and CR of the dominant hand (Figure 2). All except ten patients had T1-
weighted post-Gd images for assessment of synovitis and flexor tenosynovitis 
In paper III, we included 85 patients with available clinical data (assessment of tender finger 
joints) and MRI scans (T1-weighted pre-Gd and STIR images) of the dominant hand 
performed on the same day or at the latest after 22 days (Figure 2). All except seven patients 
had T1-weighted post-Gd images for assessment of synovitis and flexor tenosynovitis. In 
total, 82, 83 and 84 patients completed the FIHOA, AUSCAN pain and AUSCAN stiffness 
scales, respectively. All patients completed the AUSCAN physical function and AIMS-2 
hand/finger scales and measurements of grip strength.  
 
3.3 Data collection 
A broad spectrum of variables was collected at the follow-up examination of the Oslo hand 
OA cohort, including information about demographic and disease related variables. In 
addition, the patients underwent an extensive whole body joint examination, CR of both 
hands, US of both hands, MRI of dominant hand and collection of blood and urine samples. 
Table 4 summarises the most important measures in the three papers included in the current 
thesis, and this chapter will mainly focus on these measures.  
3.3.1 Demographics and patient-reported outcomes 
The hand OA patients who consented to participate in the study received a booklet of 
questionnaires (35 pages) by postal mail approximately one week ahead of the clinical 
examination. The completed booklet was returned when they subsequently came to the 
study visit. We used the questionnaires together with clinical interviews performed by study 
nurses to obtain extensive information about demographic and disease-related variables. 
Patient-reported outcome measures that were used in paper III are described in more detail.  
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Table 4. Variables used in the analyses in paper I-III. 
  Paper I 
(n = 10) 
Paper II 
(n = 106) 
Paper III 
(n = 85) 
Demographics   
 Age x x x 
 Sex  x x x 
Patient-reported outcome measures 
 Australian Canadian hand index   x 
 Functional index in Hand OA   x 
 Arthritis Impact Measurement Scales-2   x 
Physical examination and performance-based measures 
 Tender joint count   x 
 Grip strength   x 
MRI  
 Synovitis x x x 
 Flexor tenosynovitis x x x 
 Erosions x x x 
 Cysts x x x 
 Osteophytes x x x 
 Joint space narrowing x x x 
 Malalignment x x x 
 Bone marrow lesions (BMLs) x x x 
 Collateral ligament (CL) discontinuity x x x 
 BMLs at CL insertions x x x 
Conventional radiography 
 Kellgren-Lawrence  x x 
 Osteophytes  x  
 Joint space narrowing  x  
 Erosions  x  
 Cysts  x  
 Malalignment  x  
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The Australian Canadian (AUSCAN) hand index  
AUSCAN is the most widely used patient-reported outcome measure in hand OA and 
assesses both pain (five items), stiffness (one item) and physical function (nine items) 
during the last 48 hours (115). We used the Likert scale version, which gives the patient a 
choice of five response options (0-4 scale, of which 4 represents worst health) for each of 
the 15 items. The pain dimension measures the amount of hand pain at rest, when gripping, 
lifting, turning and squeezing objects, while the stiffness dimension asks for stiffness in the 
morning. The physical dimension is capturing difficulties with the following tasks: turning 
taps, turning a round door knob or handle, doing buttons, fastening jewellery, opening a new 
jar, carrying a full pot with one hand, peeling vegetables and fruits, picking up large and 
heavy objects and wringing out washcloths. Subscale scores were obtained by calculation of 
the mean value of the assigned values scored on the questions within the subscale and then 
multiplied with the number of items in the subscale (in order to correct for missing values). 
At least three pain items and five physical function items had to be assigned by the patient 
to obtain the AUSCAN pain and physical function sum scores respectively.  
The Function Index in Hand OA (FIHOA) 
FIHOA is originally an investigator-administered hand OA-specific instrument and consists 
of ten questions about functional impairment on a four-point Likert scale (0-3 scale, of 
which 3 represents worst health) (118). In the Oslo hand OA cohort, the patients completed 
the questionnaire. Total score was obtained by calculation of the mean value of the assigned 
values scored on the questions and then multiplied with ten (in order to correct for missing 
values). At least six items had to be assigned.  
The Arthritis Impact Measurement Scales-2 (AIMS-2) 
AIMS-2 is a multidimensional instrument that was initially developed for RA, but it can 
also be used in other rheumatic joint diseases like OA (119). It consists of 57 items covering 
12 dimensions of health status, of which one captures hand and finger function. This 
subscale consists of five questions on a five-point Likert scale (0-4, of which 4 represents 
worst health). The subscale score was obtained by calculation of the mean value of the 
assigned values scored on the questions within the subscale and then multiplied five (in 
order to correct for missing values). At least three items had to be assigned.  
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3.3.2 Physical examination and performance-based measures 
One rheumatologist (Barbara Slatkowsky-Christensen) with 20 years experience in 
rheumatology performed the clinical joint assessment. Absence or presence of tenderness 
upon palpation / pain on moving was assessed in the bilateral thumb base, MCP, PIP 
(including the thumb) and DIP joints as described in the EULAR hand book (paper III) 
(183). The joint examination also included assessment of soft tissue swelling, bony 
enlargement and limited motion, but these joint abnormalities were not used as outcome 
measures in the current thesis.  
Grip strength (kg) was assessed in both hands with a Jamar hand dynamometer (Therapeutic 
Equipment Corporation, Clifton, New Jersey, USA) with the patients sitting with the 
shoulder in neutral position and 90 degrees flexed elbow (125). The best performance out of 
two attempts was recorded for each hand. In this thesis, we used measurements of the hand 
that was imaged by MRI (paper III).  
3.3.3 Magnetic Resonance Imaging (MRI) 
An 1.0 T extremity MRI scanner (ONI, General Electric Healthcare, Waukesha, Wisconsin, 
USA) was used for all examinations. The patients rested in a comfortable chair during the 
examination with their hand resting in a cylindrical coil (diameter 10 cm). The hand was 
fixed to a plate and the space around the plate and hand was filled with rubber sponge to 
ensure extended fingers and reduce motion artefacts.  
The image sequences were tested in a pilot study in collaboration with a musculoskeletal 
radiologist (Sølve Sesseng, SS) and MRI technicians. Coronal, sagittal and axial T1-
weighted fat-saturated pre- and post-Gd (0.1 mmol Gd/kg body weight; Magnevist, Bayer 
Schering Pharma AG, Leverkusen, Germany) images were acquired from a 3D dual-echo 
Dixon technique (131) in addition to coronal and axial STIR images (Table 5). Both T1 and 
T2 differences may contribute to the contrasts on the STIR sequence, but in this protocol the 
T1 contrast was made dominant due to short TE time (Table 5).  
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Table 5. Details of the MRI sequences.  
Sequence Flip 
angle 
Contrast TR TE ST Gap FOV  Matrix  Time 
 
3D GRE 
fat-sat. 
15 Pre 20 5 1 0 130 224*224 5:52 
3D GRE 
fat-sat. 
15 Post 20 5 1 0 130 224*224 5:52 
COR 
STIR 
90 Pre 2850 16.3 2 0.2 130 256*192 4:45 
AX 
STIR 
90 Pre 3150 21 3 1 120 256*192 5:09 
3D-GRE fat-sat = three-dimensional gradient echo with fat saturation, COR STIR = coronal Short Tau 
Inversion Recovery, AX STIR = axial Short Tau Inversion Recovery. TR = repetition time (milliseconds), TE 
= echo time (milliseconds), ST = slice thickness (millimetres), gap = gap between the slices (millimetres), 
FOV = field of view (millimetres), time = time (minutes:seconds) required to obtain sequences.  
The development of the MRI scoring system for hand OA and its reliability are described in 
paper I. Three readers (Ida K. Haugen, IKH; Pernille Bøyesen, PB; Siri Lillegraven, SL) 
read ten sets of MRI scans unaware of clinical and radiographic data (not anonymous). The 
readers had different levels of experience; PB and SL (both medical doctors) had experience 
in reading MRI scans in inflammatory arthritic diseases and were members of the MRI 
group in OMERACT. IKH had no previous training in reading MRI scans but had 
experience in reading hand radiographs for presence and severity of OA (184). The reading 
was repeated after 1 week, and we calculated the intra-reader and inter-reader reliability. 
Prior to the second part of the reliability exercise, an external person anonymised, recoded 
and rearranged the ten MRI scans in a different order. The score sheets from the first 
reading were unavailable for the readers until the second reading was completed. All readers 
read the MRI scans independently at different workstations (screens of 24-27 inches). We 
used Picture Archiving and Communication System (PACS) Sectra (IDS5, SECTRA, 
Linköping, Sweden) and OsiriX (OsiriX, Geneva, Switzerland) software in the first and 
second part of the reliability exercise respectively. These software packages allow the 
reader to adjust window/level settings, such as the ability to zoom in/out, use a localiser to 
accurately place a specific lesion in two planes and measurement of distances.  
All MRI scans were later read according to the proposed MRI scoring system (paper I) 
unaware of clinical and radiographic data (paper II and III): Osteophytes (grade 0-3; 
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distal/proximal part of the joint), JSN (grade 0-3), cysts (absence/presence; distal/proximal), 
malalignment (absence/presence; frontal/sagittal plane), synovitis (grade 0-3), flexor 
tenosynovitis (grade 0-3), BMLs (grade 0-3; distal/proximal), collateral ligament 
discontinuity (absence/presence; radial/ulnar) and BMLs at collateral ligament insertions 
(absence/presence; distal/proximal and ulnar/radial). Erosions (grade 0-3; distal/proximal) 
and bone attrition (absence/presence; distal/proximal) were scored separately in contrast to 
the proposed combined definition and grading. Two readers (IKH, PB) in consensus read 
the ten first MRI scans, while the remaining images were read by IKH alone. IKH re-scored 
ten randomly selected MRI scans after a period of at least 7 weeks, and the intra-reader 
reliability was assessed (paper II-III). All MRI scans were read on large screens (24 inches) 
with use of PACS Sectra software.  
3.3.4 Conventional radiography (CR) 
Digital bilateral hand radiographs with posteroanterior view were obtained in 102 of 106 
patients, whereas 4 patients only imaged the right hand (same hand as imaged by MRI) 
(paper II).  
The finger joints (DIP, PIP including the thumb, MCP and CMC-1) were graded according 
to the KL scale and the OARSI atlas (13, 170). The KL scale gives a global score of the 
DIP, PIP, MCP and CMC-1 joints on a 0-4 scale based on the presence and size of 
osteophytes, JSN, sclerosis, cysts and altered shape of bony ends: 0 = no OA, 1 = doubtful 
OA, 2 = definite minimal OA, 3 = moderate OA, 4 = severe OA (13). Epidemiological 
studies often use KL grade 2 or above as the definition of OA.  
The OARSI atlas shows example images of different grades of individual radiographic OA 
features such as osteophytes (grade 0-3), JSN (grade 0-3), erosions (grade 0-1), 
pseudowidening (grade 0-1), cysts (grade 0-1), sclerosis (grade 0-1) and malalignment 
(grade 0-1). According to the published atlas, osteophytes and JSN should be scored in the 
DIP, PIP (including the thumb), CMC-1 and naviculotrapezial joints; malalignment, 
sclerosis and erosions in the DIP, PIP and CMC-1 joints; pseudowidening in the DIP joints; 
cysts in the PIP and CMC-1 joints. In this study, all features were scored in the DIP, PIP 
(including the thumb), MCP and CMC-1, as done for the KL scale.  
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IKH read the CR images on the same workstations as for the MRI scans with use of PACS 
Sectra software. The readings were performed blinded for clinical and MRI data. The same 
reader (IKH) re-scored thirty randomly selected radiographs (not anonymised) after a period 
of at least 2 weeks. These radiographs were also assessed by a second reader (Jessica 
Bijsterbosch, JB) from the Department of Rheumatology at Leiden University Medical 
Centre for calculation of inter-reader reliability. IKH and JB had previously collaborated in 
a multicentre study about the reliability of different radiographic scoring systems for hand 
OA. This study was led by rheumatologist Margreet Kloppenburg (MK), a leading expert in 
the field of hand OA, and her research group at Leiden University Medical Centre (184), 
and IKH was trained for reading hand radiographs in Leiden under supervision of a 
musculoskeletal radiologist (Iain Watt) and MK.  
3.3.5 Blood samples 
A blood sample was drawn from all patients. The erythrocyte sedimentation rate was used 
for the assessment of the ACR criteria for the hips (below 20 mm per hour) (185). Full-
blood and serum have been frozen in a biobank for later use.  
 
3.4 Statistics 
All statistical analyses presented in this thesis were performed by IKH in collaboration with 
a statistician using the Statistical Package for the Social Sciences for Windows, versions 
17.0 (SPSS, Chicago, IL, USA). P-values below a cut-off of 0.05 were considered 
statistically significant. 
3.4.1 Descriptive analyses and group comparisons 
We present the mean and standard deviation for variables with a normal distribution. 
Several variables, such as the number of affected joints or sum scores for the MRI features, 
had a skewed distribution with a right tail, and we present the median and interquartile 
range. We calculated the prevalence of MRI features across joints with different grades of 
radiographic severity (KL grades) (paper II) and the prevalence of tenderness in joints with 
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different grades of MRI pathology (paper III) as counts with percentages. The number of 
affected joints by MRI and CR was compared by Wilcoxon signed-rank test (paper II).  
3.4.2 Reliability 
We assessed the reliability of the MRI readings using three statistical methods (paper I): the 
intraclass correlation coefficient (ICC) as a relative measure of reader agreement in addition 
to the smallest detectable difference (SDD) and percentage exact and close agreement 
(PEA, PCA) as absolute measures of agreement. We have also presented the reliability of 
readings of MRI and CR with use of unweighted/weighted kappa (κ) in paper II and III.  
ICC is used to measure reliability when data are considered to be on an interval level (186). 
In the current context, ICC can be conceptualised as the ratio of the variance between the 
two readings (of the same patient) to the total variance (all patients). We used the sum 
scores of the different MRI and radiographic features and calculated the single and average 
measure ICCs (SmICCs and AvmICCs) for intra-reader and inter-reader reliability 
respectively. AvmICC corrects for the number of readers. We considered the cases (here: 
patients) to be a random sample from a larger population, while the readers were entered as 
a fixed effect (i.e., not random selection). Thus, the analyses were performed with two-way 
mixed effect models. Agreement was defined in terms of absolute agreement (as opposed to 
consistency). ICC was interpreted similar to κ (see below) with 1.0 as perfect agreement but 
with no lower limit (negative estimates may occur).  
The SDD represents the smallest difference that can be discriminated from the measurement 
error. The calculation of SDD was based on the Bland and Altman’s 95% limits of 
agreement method; intra-reader SDD was calculated as 1.96 multiplied with the standard 
deviation of the mean difference between the two status scores (187), and inter-reader SDD 
as the pooled within-subject standard error of measurement (SEM) multiplied with 
(1.96*√2) and then divided by the square root of the number of readers (√3) (188, 189). 
SEM represents the square root of the error (residual) variance. SDD = 0 is perfect 
agreement, but there is no convention regarding any upper limit and it depends on the 
distribution of the data.  
PEA was calculated as the percentage of occasions of which the scoring value was identical 
between all readers (i.e., inter-reader) or between the first and second reading (i.e., intra-
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reader), and PEA = 100% is perfect agreement. PCA was similarly calculated as the 
percentage of occasions of which the difference was ≤1 (not applicable for features scored 
as absent/present), and should ideally approach 100%. 
Cohen´s κ takes into account the agreement occurring by chance and is frequently used for 
assessment of reliability of categorical items if there are only two readers or readings (190). 
Interpretation of κ is often based on the guidelines by Landis and Koch (191): < 0: no 
agreement, 0–0.20: slight, 0.21–0.40: fair, 0.41–0.60: moderate, 0.61–0.80: substantial, and 
0.81–1.0: almost perfect agreement. There are difficulties in interpretation of κ, since κ is 
affected in complex ways by the presence of bias between the readers/readings and by the 
distribution of data across the categories (192). Weighted κ is useful when there are ordered 
response categories and takes into account the seriousness of disagreement (193).  
3.4.3 Test performance 
Sensitivity and specificity are statistical measures of the performance of a binary 
classification test (here: MRI). Sensitivity measures the proportion of actual positives, 
which are correctly identified as such (a / a+c), while specificity measures the proportion of 
negatives correctly identified (d / b+d) (Table 6). We calculated the sensitivity and 
specificity of MRI in detection of structural OA features (dichotomised at joint level as 
absent/present) with CR used as reference (paper II). 
As a measure of accuracy, we similarly calculated the PEA as the proportion of “true 
positive” and “true negative” results (a+d / a+b+c+d) (Table 6). For features that were 
scored on 0-3 scales with both modalities, we calculated the PEA across the categories and 
the PCA as the proportion of which the difference was < 1 between the two modalities 
(paper II).  
Table 6. Overview of test performance and accuracy of MRI. 
Conventional radiography 
(“gold standard”) 
 
Present  Absent 
Present a b MRI    
(classification test) 
Absent c d 
 
 45 
3.4.4 Univariate and multivariate regression analyses 
We calculated the odds ratio (OR) of having MRI pathology present in joints with different 
levels of radiographic severity with use of logistic regression analyses with Generalised 
Estimating Equations (GEE) models in order to adjust for several joints within one patient 
(i.e., within-subject dependency) (paper II). Joints with no radiographic OA (KL grade = 0) 
served as references, and the analyses were adjusted for age and sex.  
We similarly calculated the OR of tenderness in joints with MRI pathology present using 
logistic regression analyses with GEE models (paper III). Joints without the current MRI 
feature served as reference, and the analyses were adjusted for age and sex (corrected 
univariate analyses). Variables with a p-value < 0.25 in corrected univariate analyses were 
included in a multivariate model (adjusted for age and sex), and the variables were removed 
from the model one by one with backward selection. The final model included variables that 
were associated with joint tenderness with a p value < 0.10 (adjusted for age and sex). The 
multivariate analyses were also repeated with forward selection of variables.  
We used an unstructured correlation matrix (paper II and III), which means that the model 
uses the data to estimate the covariance between the repeated measurements (here: several 
joints within one person). For one exception (paper II) we used an independent correlation 
matrix, which is a simpler model, due to inability of the model to finalise the estimation 
process.  
 
3.5 Legal and ethical aspects 
The study was conducted according to the ethical principles of the Declaration of Helsinki. 
All participants gave their written informed consent prior to entering the study. The regional 
ethical committee approved the study, and the Data Inspectorate approved the storage of 
data.  
 46 
4. Summaries of results 
4.1 Paper I 
Hand osteoarthritis and MRI: Development and first validation step of the proposed 
Oslo Hand Osteoarthritis MRI score 
In this paper, we introduced a novel MRI scoring system for the DIP and PIP joints in hand 
OA and tested the intra-reader and inter-reader reliability. The scoring system contained the 
following features: Synovitis (Gd enhancement, grade 0-3), flexor tenosynovitis (Gd 
enhancement, grade 0-3), erosions (including subchondral bone collapse, grade 0-3), 
osteophytes (grade 0-3), JSN (grade 0-3), BMLs (grade 0-3), cysts (grade 0-1), 
malalignment (grade 0-1), collateral ligament discontinuity (grade 0-1) and BMLs at the 
insertion sites of the collateral ligaments (grade 0-1). Erosions, osteophytes, BMLs and 
cysts were assessed in the proximal and distal part of the joint separately, whereas 
malalignment was assessed in the frontal and sagittal plane.  
We proposed a definition for each of the features and their grades and developed an atlas 
with example images in order to facilitate the scoring.  
In the reliability exercise, three readers read ten MRI scans independently, and the readings 
were repeated after one week after anonymisation and rearrangement of the images. Inter-
reader reliability was very good for synovitis, erosions, osteophytes, JSN, malalignment 
(frontal plane) and BMLs (ICCs ≥ 0.83, PCA ≥ 89%), and good for flexor tenosynovitis 
(ICC = 0.64, PCA = 80%) and collateral ligament discontinuity (ICC = 0.79, PEA = 63%). 
Cysts, malalignment (sagittal plane) and BMLs at the insertion sites of the ligaments 
showed high PEA (≥ 85%), but poor to moderate ICCs (0.00–0.59), which was probably 
due to low prevalence. The estimates for intra-reader reliability were of similar magnitude 
as the estimates for inter-reader reliability but lower for synovitis (ICC = 0.48).  
Our results suggest that the proposed Oslo MRI score for hand OA can reliably assess hand 
OA features, but further validation is needed.  
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4.2 Paper II 
Comparison of features by MRI and radiographs of the interphalangeal finger joints 
in patients with hand osteoarthritis 
The main objectives of this paper were to examine the spectrum of MRI pathology, to 
investigate the construct validity of MRI-defined structural hand OA features with CR as 
reference, and to explore the association between MRI-defined pathology and radiographic 
severity in 106 patients with hand OA.  
The patients had contrast-enhanced MRI and CR of the DIP and PIP joints of the dominant 
hand available. The MRIs were scored according to the proposed Oslo hand OA MRI score 
(presented in paper I). However, we chose to score erosions and attrition separately as 
opposed to the proposed combined scoring. The hand radiographs were scored according to 
the KL scale and the OARSI atlas for individual radiographic features.  
We found very good agreement between MRI-defined attrition and radiographic central 
erosions (PEA = 92%, κ = 0.75), whereas MRI detected almost twice as many joints with 
attrition and/or erosions as compared to joints with radiographic central or marginal 
erosions. MRI and CR agreed about absence or presence of erosions/attrition in 71% of the 
joints; the sensitivity of MRI was very high (95%), whereas the specificity was lower 
(63%). MRI also detected almost twice as many joints with osteophytes as compared to CR. 
The agreement between MRI and CR was only moderate (PEA = 37%, weighted κ = 0.50) 
due to poor specificity of MRI (22%), although the sensitivity was perfect (100%). PCA 
was very high (94%) indicating that MRI detected many small osteophytes in joints that 
appeared radiographically normal. MRI and CR detected similar number of joints with JSN, 
cysts and malalignment, but the agreement on individual joint level was poor to moderate.  
The prevalence of most MRI features increased with radiographic severity, but moderate to 
severe synovitis was more frequent in joints with mild OA (OR = 2.1, 95% CI 1.4 to 3.2) 
than in moderate/severe OA (OR = 1.4, 95% CI 1.0 to 2.2) (joints without OA as reference). 
We concluded that MRI detected more erosions than CR, suggesting that erosive hand OA 
may be more common than previously indicated by CR. Synovitis was most common in 
mild OA, but whether this is due to burn-out of inflammation in late disease must be further 
investigated.  
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4.3 Paper III 
Associations between MRI-defined synovitis, bone marrow lesions and structural 
features and measures of pain and physical function in hand osteoarthritis.  
The main objective of this paper was to explore the associations between MRI features and 
measures of pain and physical functioning in 85 patients with hand OA.  
The patients fulfilled questionnaires about hand pain and physical functioning, underwent a 
clinical examination with assessment of joint tenderness and measurement of grip strength 
as well as contrast-enhanced MRI of the dominant hand within 22 days after the clinical 
examination. The MRI scans were scored according to the proposed Oslo hand OA MRI 
score (presented in paper I). 
In our multivariate model, we found that the following MRI features were associated with 
tenderness in the same joint (adjusted for age and sex): Osteophytes (OR = 1.4, 95% CI 0.9 
to 2.1), erosions (OR = 1.4, 95% CI 1.0 to 1.9), bone attrition (OR = 2.5, 95% CI 1.5 to 4.1), 
moderate/severe synovitis (OR = 2.4, 95% CI 1.6 to 3.8) and BMLs (OR = 1.5, 95% CI 1.0 
to 2.3). Synovitis and BMLs were also associated with joint tenderness independent of 
radiographic severity (multivariate model with both features, adjusted for KL grade, age and 
sex). 
We found no significant associations between the amount of MRI pathology and the 
AUSCAN pain, AUSCAN physical functioning or AIMS-2 hand/finger subscales. The sum 
score of MRI-defined attrition was associated with FIHOA (B = 0.58, 95% CI 0.18 to 0.97), 
while the sum score of osteophytes was associated with grip strength (B = -0.39, 95% CI -
0.58 to -0.21).  
We concluded that MRI-defined synovitis, BMLs, erosions and attrition were associated 
with tenderness in the same joint, whereas the associations to patient-reported pain and 
physical functioning and grip strength were limited. Synovitis and BMLs may represent 
targets for therapeutic interventions in hand OA. 
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5. General discussion 
5.1 Methodological aspects 
Methodological limitations of the studies included in this thesis may contribute to bias, 
defined as systematic deviations from the truth. Bias is the result of problems in the design 
and conduct of the study. The following sections describe how these limitations may have 
affected our results, and methodological strengths are also addressed.  
5.1.1 Study design 
In all three papers we used a cross-sectional study design.  
In paper I, we applied a cross-sectional test-retest design and calculated the intra-reader and 
inter-reader reliability for status scores. We were not able to assess the reliability for change 
scores due to the lack of longitudinal data. In the reliability exercise, the retest was 
performed approximately one week after the first scoring session, and all cases had been 
anonymised, recoded and reorganised in a different order. Despite a limited number of 
patients (n = 10), we considered it unlikely that the readers remembered the scores from the 
first reading. 
In paper II and III, we examined the validity of MRI against CR and measures of pain and 
physical function in a cross-sectional setting. The strengths of this cohort include the 
extensive data collection with information about imaging findings, clinical examination and 
patient-reported outcomes. To our knowledge, the Oslo hand OA cohort is currently the 
largest hand OA cohort with MRI data worldwide.  
We found that MRI was more sensitive than CR in detection of structural features such as 
osteophytes and erosions, and that structural features as well as synovitis were frequently 
present in joints without definite radiographic OA (paper II). These results may suggest that 
MRI detects OA features at an earlier time point than CR. However, whether these joints 
develop future radiographic OA features remains speculative due to the lack of longitudinal 
data. Longitudinal studies are also needed in order to examine whether MRI is more 
sensitive in detection of OA progression and whether synovitis can predict future 
radiographic OA. Although not part of this thesis, we are planning a follow-up examination 
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(including MRI) of these patients, allowing us to explore the value of MRI in a longitudinal 
setting.  
MRI-defined erosions, attrition, synovitis and BMLs were cross-sectionally associated with 
joint tenderness (paper III). Multiple OA features are commonly co-occurring, which may 
lead to a high risk of confounding in a cross-sectional study. We tried to limit the risk of 
confounding by doing multivariate analyses with inclusion of all MRI features that were 
associated with joint tenderness in the same model. Confirmation of these associations in 
future longitudinal studies is needed to further increase the validity of the results. It should 
be explored whether progression of these features is associated with pain onset or 
worsening. However, simultaneous progression of other structural lesions may also 
confound such findings. The problem of confounding by structural OA progression may be 
circumvented by exploring whether reduction or complete resolution of synovitis and BMLs 
is accompanied by less joint tenderness.  
5.1.2 Representativity of the study sample 
Selection bias is a systematic error due to a non-random sample of a population, causing a 
higher likelihood of inclusion in the study for some members of the population than others. 
When the assumptions of randomness and representativity cannot be assumed, we can only 
draw limited conclusions (194). Selection bias may affect both the internal and external 
validity of our results. Internal validity refers to whether the obtained results reflect the 
“truth” within the study population, whereas external validity refers to the generalisability 
of the study results (194). 
Initially 209 participants were included in the Oslo hand OA cohort. The participants were 
recruited from the outpatient clinic at Diakonhjemmet Hospital in 2001-03 and had most 
frequently been referred from their general practitioner due to hand OA or questions about 
differential diagnoses such as inflammatory rheumatic diseases. In total 275 patients with 
hand OA were initially identified as eligible for the study. Of those, 209 (76%) consented to 
participate in the baseline data collection (questionnaires/interview, clinical examination 
and CR of both hands). 
In this thesis, we used data from the follow-up examination in 2008-09, of which 128 of the 
209 original participants (61%) attended. Whether the non-responders did not meet due to 
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improvement (i.e., the patients did not see any need to participate in the study) or worsening 
of symptoms (i.e., the patients were too physically impaired to meet at or travel to the 
hospital for examination) is unknown.  
Hence, the participants were possibly selected at baseline based on structural disease, high 
amount of inflammation or severe symptoms, which were our exposure and outcome 
variables in paper II-III. For example, we can anticipate that persons with Heberden´s nodes 
(as signs of structural disease) or hand pain are more likely to seek their general practitioner 
and thereafter be referred to the rheumatology clinic. Conditioning on the common effect 
(here: seek doctor) may affect the association between the exposure (here: structural 
disease) and outcome (here: pain) (i.e., the internal validity). The majority of participants in 
this cohort fulfilled the ACR clinical hand criteria, which means that the majority had both 
hand pain and also bony enlargement of the finger joints. Hence, the association between 
the exposure variables (here: MRI features as measures of structural disease) and outcome 
variables (here: pain) is not only the result of the causal effect of exposure on outcome 
(195). This may have affected our results on the analyses performed at patient level 
examining the association between the amount of MRI pathology and measures of hand 
pain and function (paper III). The association between MRI features and tenderness in the 
same joint is probably less affected by selection bias, and these analyses performed at 
individual joint level were therefore the main focus in this thesis.  
The generalisability of our results (i.e., the external validity) to the general population of 
hand OA patients is limited due to the selection process described above and the 
overrepresentation of women and elderly patients. Hence, caution should be applied in the 
interpretation of the results on a population level.  
Hand OA is often considered as a women’s disease. However, we recently studied the 
prevalence, incidence and progression of radiographic hand OA in the general population of 
Framingham and found that radiographic hand OA was only slightly lower in men (38%) 
compared to women (44%) with age between 40 and 84 years. OA in certain joint groups 
(MCP and wrist joints) and age groups (below 60 years) was even slightly higher in men. 
Hence, radiographic hand OA seemed to be a disease of both sexes in contrary to the 
common conception of hand OA as a women´s disease. However, despite similar prevalence 
estimates of radiographic disease, we found that symptomatic hand OA was twice as 
prevalent in women (16%) as in men (8%) (3). Similar sex differences have been shown in 
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clinical and experimental studies of several chronic pain conditions (196), suggesting 
differences in pain sensitivity, cognitive/affective mechanisms and/or pain reporting 
between men and women. Higher occurrence of erosive hand OA and possibly more severe 
structural disease in women may also contribute to the observed differences of symptomatic 
hand OA between women and men. Although symptomatic hand OA is more common in 
women than men, we had a higher women-to-men ratio in the Oslo hand OA cohort than 
seen in most population-based studies of hand OA (3, 197, 198). One possible explanation 
for the high women-to-men ratio in this study may be that women are more likely to seek 
medical care and were therefore more likely to be recruited in this study.  
Notification and exclusion of patients with differential diagnoses are important for the 
diagnosis of hand OA (11). Those with diagnoses of inflammatory joint diseases such as 
PsA, RA and gout as well as hemochromatosis were not included in the Oslo hand OA 
cohort. However, the initial symptoms and signs of hand OA may be difficult to distinguish 
from inflammatory joint diseases, and in total 4 patients were excluded during the period 
between baseline and follow-up due to (possible) diagnosis of either RA or PsA. One single 
criterion on its own has limited sensitivity and specificity for differentiation between hand 
OA and inflammatory joint diseases, and the diagnosis should therefore be based on a 
composite of multiple features such as age, sex, joint distribution and bony enlargement of 
the finger joints (11). Laboratory test may also assist the process. Studies have shown that 
patients with erosive hand OA do not have anti-cyclic citrullinated peptide (anti-CCP) 
antibodies or rheumatoid factor isotypes (199, 200). However, neither rheumatoid factor, 
anti-CCP nor urate were measured in this study.  
One main advantage of the Oslo hand OA is the comprehensive data collection. Clinical 
examination and imaging assessment require allocation of space and trained staff (such as 
rheumatologists, nurses and radiology technicians), and especially the MRI scans are 
associated with high costs. A similar detailed assessment would be more difficult and very 
expensive to perform in a large population-based cohort that was selected neither on the 
exposure nor the outcome variables.  
Other studies examining the validity of MRI features in hand OA patients have been 
performed in Leeds (United Kingdom), Ghent (Belgium) and Leiden (the Netherlands), and 
all studies used similar study designs with patients recruited from the outpatient clinics. 
Grainger et al. compared high-resolution MRI (hrMRI) and CR in 15 patients (14 women) 
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with hand OA based on the ACR criteria, who were recruited from the outpatient clinic 
(150). Wittoek et al. (Ghent University) also recruited 14 patients (10 women) from their 
rheumatology outpatient clinic, and all participants fulfilled the ACR clinical criteria for 
hand OA (201). Kwok et al. (Leiden University Medical Centre) similarly recruited 16 
patients (10 women) with hand OA from the outpatient rheumatology clinic, and all fulfilled 
the clinical ACR criteria (202). Hence, all studies have similarities with the Oslo hand OA 
cohort with regard to patient enrolment. At the publication date, the Oslo hand OA cohort is 
by far the largest hand OA cohort with hand MRI of the participants.  
5.1.3 Self-reported measures and clinical examination 
The data collection in the Oslo hand OA cohort aimed to include similar dimensions of 
assessment that had been frequently used in outcome research for RA, including patient-
reported outcomes, functional performance-based tests, clinical joint assessment and 
imaging. In line with an opinion paper by Kloppenburg et al. regarding the need for 
research in hand OA, our data collection included components of both disease activity, 
function and damage (203).  
Self-reported measures of pain and physical functioning are frequently used in 
rheumatology research and within the field of OA. The advantage of self-reported 
instruments is that they are often more feasible in a busy clinical setting, as they do not 
require the presence of any trained staff and allocation of space. In this thesis, a large range 
of instruments were completed by the patients, such as the AUSCAN, FIHOA, AIMS-2, 
Health Assessment Questionnaire (HAQ), Short Form (SF)-36 (115, 118, 119, 204, 205). 
Other hand OA specific measures like the SACRAH, Cochin and Michigan questionnaires 
were not included in the data collection in order to prevent a too comprehensive booklet for 
the patients (116, 117, 206). In this thesis (paper III), we focused on questionnaires about 
hand pain and functioning like the AUSCAN, FIHOA and AIMS-2. Hence, HAQ and SF-36 
were not included.  
Factors such as educational level and the motivation of the patients as well as their personal 
preferences and perception of normality may affect how the patients complete the 
questionnaires. Thus, self-reported measures may therefore not always correlate with 
objective measures of physical functioning. Within ICF, self-reported instruments measure 
the functioning from the perspective of a person’s life, while objective hand function tests 
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measure the capacity of a person to perform a certain task (112). Although measurement of 
grip strength gives an objective performance-based measure, it only measures some aspects 
of hand functioning. The ability to perform tasks requiring hand manipulation is for 
example not assessed by grip strength. The Moberg Pick-up test was also performed in our 
cohort (126), but the test was not included in the analyses in the current thesis. We chose to 
focus on grip strength since this is a more well-established instrument.  
One single rheumatologist (BSC) with more than 20 years experience within the field of 
rheumatology performed the clinical joint examination in order to avoid inter-rater bias. 
Tender joints by palpation/movement, bony enlargement, soft tissue swelling and limited 
motion were assessed, but only tender joints were used as an outcome measure in this thesis 
(paper III). Self-reported pain in the individual hand joints was not assessed. Compared to 
self-reported measures of hand pain, the clinical examination of joint tenderness probably 
limits the role of psychosocial factors related to pain reporting.  
5.1.4 Magnetic resonance imaging (MRI) 
We know from numerous studies that hand OA has a predilection of the DIP, PIP and 
thumb base joints (3, 19, 20). The MCP joints are less frequently affected, and MCP OA 
seems to be more prevalent in men than women (3). Erosive hand OA is typically occurring 
in the DIP and PIP joints (3), although erosive OA of the thumb base has also been reported 
(29). The joints are usually symmetrically affected (198), and there are inconsistent results 
regarding whether OA is more common in the dominant hand (65-67). In the Framingham 
study, we found slightly higher prevalence of OA in the DIP and PIP joints in the right 
hand, whereas thumb base OA was more common in the left hand (3).  
The patients in this study underwent bilateral hand radiographs, while only the DIP and PIP 
joints of the 2nd-5th finger of the dominant hand were imaged by MRI. The MCP joints were 
in most patients uncovered or incompletely covered due to limited FOV, whereas imaging 
of the thumb base joint would have required a separate acquisition. The selection of 
sequences was based on the current recommendations for RA and PsA (158, 162), and the 
sequences were developed in collaboration with an MRI technician and a musculoskeletal 
radiologist (SS). Based on the recent papers by Tan et al. (110, 207), we aimed to get an 
adequate visualisation of the collateral ligaments. Sequences were tested on healthy controls 
and patients in a pilot study. The decision about which joints to scan by MRI and the final 
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selection of sequences were based on considerations about joint distribution, burden on the 
patients, feasibility and economical costs.  
We obtained T1-weighted images with a 3D GRE sequence. This sequence allows 
acquisition of nearly isotropic voxels and is therefore ideal for accurate quantitative 
assessment of cartilage thickness and volume in the knee. In this thesis, the sequence was 
selected due to low scanning time and adequate visualisation of the ligaments. However, the 
technique has some disadvantages. The sequence provides only limited contrast between 
cartilage and fluid, and it was not possible to differentiate between cartilage and synovial 
fluid or between the two cartilage layers due to the small size of the finger joints. To reduce 
motion artefacts, the patients´ hands were fixed within the coil and we used an extremity 
coil, which is more comfortable for the patients than a whole-body scanner.  
3D GRE images were acquired pre- and post administration of Gd contrast. The decision of 
using contrast-enhanced images was based on the current recommendation for RA, 
suggesting that the use of contrast increase the sensitivity for detection of synovitis (142). It 
has also recently been suggested that contrast-enhanced MRI is more accurate for 
assessment of synovial inflammation and especially infiltration than T2-weighted images in 
knee OA (208), and a scoring system for synovitis with use of contrast-enhanced MRIs was 
recently developed (156). The main disadvantage of using Gd contrast is the risk of 
nephrogenic systemic sclerosis, especially in elderly patients with decreased kidney 
function. OA is more commonly occurring in elderly patients, and the patients in this thesis 
were in the range of 57 to 78 years. All participants had a blood test for creatinin levels, as a 
measure of the kidney function, prior to the MRI examination.  
The development of synovial membrane enhancement following the injection of intravenous 
Gd depends on the speed by which the Gd moves through the circulation to the small 
synovial membrane vessels and diffuse into the interstitium of the synovial membrane. If 
the joint is scanned too early after the contrast injection, the enhancement will be less 
pronounced, potentially leading to underestimation of the severity of synovitis. If the 
scanning is delayed, there will be a slowly decreasing intensity of the enhancement, 
especially in cases of synovial effusion as the contrast will equilibrate between the synovial 
membrane and effusion (132). In this particular situation, the thickness of the synovial 
membrane may be overestimated (since the space occupied by effusion is mistakenly 
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included). In this thesis, the post-Gd images were acquired immediately after administration 
of the intravenous Gd contrast.  
Bone damage and formation were evaluated on the GRE images. Cortical bone is seen as 
signal void on the GRE sequences due to the relative lack of hydrogen protons in this tissue. 
Hence, the contrast against cartilage and other structures such as the synovial fluid and 
membrane is important for the evaluation of bone erosions/attrition and osteophytes. 
However, soft tissue structures such as collateral ligaments and tendons also have a dark 
appearance on the GRE images, and it can therefore be difficult to distinguish osteophytes 
from thickened ligaments and tendons.  
Fat suppression is necessary for depiction of BMLs and can be provided by a STIR 
sequence. In this thesis, BMLs were assessed with use of coronal and axial STIR images. 
The primary advantage of the STIR sequence is the ability to produce uniform fat 
suppression, which limits the risk of misinterpretation of regions with inadequate fat 
suppression as BMLs (129). However, the inversion pulse also degrades the signal-to-noise 
ratio of the remaining signal by 40-50%, and the technique is relatively inefficient in terms 
of time (129). The slice thickness was 2-3 mm, and the STIR images were not used for 
assessment of other features than BMLs. Thick slices (i.e., larger voxels) increase the risk of 
partial volume artefacts. Partial volume artefacts occur when a structure (here: bone) is only 
partly within the voxel, and they are especially marked at the interface between tissues with 
different signal intensity such as the bone and inflamed synovium. Due to the small size of 
the finger joints, perhaps only one or two coronal slices had voxels that only contained 
bone. Both the axial and coronal planes were used for better insurance of true BMLs. High 
signal intensity of the bone in imaging sections that contained adjoining soft tissue (i.e., on 
the way “out” or “into” the bone) was interpreted as partial volume artefacts and not BMLs.  
Knowledge about the normal anatomy is important in order to not overestimate the presence 
of pathology. The collateral ligaments insert into bony recesses at the phalangeal heads, and 
presence of inflamed synovium adjacent to these bony recesses may possibly mimic the 
presence of marginal erosions as in RA (132). Furthermore, the “magic angle” phenomenon 
may lead to false appearance of increased signal intensity of the collateral ligaments (133), 
leading to overestimation of disrupted ligaments. Nutrient foramina, which are usually 
located on the palmar side in the middle third of the shaft, may also be misinterpreted as 
erosions (209). 
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5.1.5 Conventional radiography (CR) 
In this thesis, only the radiographs with posteroanterior view were scored for presence and 
severity of OA features and used in our analyses. Traction spurs at the insertion sites of the 
extensor tendons are most easily seen on lateral and oblique images, and the use of images 
with posteroanterior view only may have led to an underestimation of bone proliferation.  
The images were scored according to the KL scale and OARSI atlas. The KL scale has been 
criticised for too much emphasis on osteophytes (176), as narrowed/sclerotic joints cannot 
be classified as having OA unless osteophytes are present. In the original paper from 1957, 
the different grades were described as: 0 = no OA, 1 = doubtful OA, 2 = minimal OA, 3 = 
moderate OA, 4 = severe OA, and example images were shown (13). In the atlas from 1963, 
also written descriptions of the example images were included. However, the definition of 
the grades differed between hand joint groups. As an example, a DIP joint with KL grade = 
2 was described as “definite osteophytes at two points…., but good joint space”, while a PIP 
joint with KL grade = 2 was described as “definite osteophytes at two points and possible 
narrowing of joint space” (14). The latter description is similar to the description of a knee 
joint with KL grade = 2. Furthermore, according to a later publication by Lawrence in 1977, 
a joint should be scored as having KL grade = 2 when there is “a definite osteophyte, but 
unimpaired joint space”, and grade 3 and 4 in case of moderate and severe JSN respectively 
(175). Hence, it remains unclear how to grade joints with possible or mild JSN. In this 
thesis, we chose to classify joints as having KL grade = 2 based on the presence of definite 
osteophytes with or without accompanying possible/mild JSN (as described for the PIP and 
DIP joints respectively). Joints with only mild JSN but not definite osteophytes were 
therefore scored as normal (n = 248). We decided to score joints with moderate to severe 
JSN but no osteophytes as KL grade = 1 (n = 65). Thus, several of the joints with KL grade 
0-1 had JSN. This means that OA pathology may be present in joints with KL grade 0-1 
since the atlas does not allow scoring of these features as definite OA. This limitation of the 
KL scale should be kept in mind when interpreting the results in paper II.  
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5.2 Main results 
5.2.1 Development of an MRI scoring system for hand OA 
The development of the MRI scoring system for hand OA (paper I) was based on a similar 
process as had been done for the RAMRIS and PsAMRIS in OMERACT (158, 162).  
The first step in the development of the MRI score included selection of pathological 
features based on a literature review and informal group discussions. The next step was to 
perform reliability exercises (three in total), of which the results from the last exercise were 
presented in paper I. Only inter-reader reliability was assessed in the first two exercises, and 
the results from the second exercise were presented at the EULAR congress in 2010 (210). 
We did additional training for features with low reliability, and modifications of the features 
were performed if necessary.  
Since OA is a disease affecting the whole joint, we started with a broad inclusion of 
features, such as structural key hand OA features, inflammatory features and BMLs. We 
also initially assessed extensor tendinitis, since this feature was included in the initial 
exercises of PsAMRIS (162). Based on recent studies by Tan et al. we included assessment 
of different forms of collateral ligament pathology (110, 207), such as normal/disrupted, 
non-thickened/thickened and non-inflamed/inflamed ligaments. During/after the first two 
exercises, we excluded ligament thickening, ligament inflammation and extensor tendinitis 
from the scoring system due to no/infrequent appearance and/or low reliability. The MCP 
joints were also excluded from the scoring system after the first exercise due to 
incomplete/varying coverage by the FOV.  
The final definition of bone damage included both assessment of focal bone loss 
(“erosions”) and attrition of the joint plate (“subchondral bone collapse”). We realised that 
the initial definition of erosion (“a sharply marginated bone lesion, which is visible in two 
planes with a cortical break seen in at least one plane”) did not capture the typical central 
erosions, which are often seen as “seagull wing” configurations. Hence, according to our 
final definition, grade 1 included either 1-2 small erosions and/or subchondral bone 
collapse. Despite this combined definition, we chose to score these two features separately 
for paper II-III. This decision was based on the awareness of previous studies suggesting 
different pathogenic processes behind these two features (150). Further, the presence of 
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subchondral bone collapse alone was only scored as a grade 1, and it is questionable 
whether presence of small erosions and possibly severe collapse of the joint plate can be 
equated. In paper II and III, we changed the wording from “subchondral collapse” to 
“attrition” in order to have the same wording as used for knee OA (151), and in order to 
have a wording based on the appearance and not the possible underlying pathogenic 
mechanisms. Initially, we proposed a grading of erosions on a 0-10 scale based on the 
volumetric bone loss (similar to PsAMRIS) (162). However, most of the erosions in our first 
two reliability exercises were scored as grade 1, even though the joints were considered as 
severely damaged (210). Hence, we changed the grading to a 0-3 scale, which was rather 
based on the size and numbers of erosions. One could possibly argue that a combined score 
of attrition and erosions as originally proposed is preferred in order to increase the 
feasibility of the scoring system. A combined score based on the volumetric size of erosions 
and the percentage of the joint plate that is erosive may represent one possible solution, 
which should be included in the future research agenda.  
BMLs, cysts and erosions may have a similar appearance but were included as separate 
features in our scoring system. By definition, BMLs have a more diffuse border than cysts 
and erosions, and they are most easily detected on STIR or fat-suppressed T2-weighted 
sequences. The definitions of cysts and erosions were similar, as the difference was only the 
absence or presence of a cortical break respectively. However, the small size of the DIP and 
PIP joints and a field strength of only 1.0 T may complicate the judgement about whether a 
thin cortical rim is present or not. The cause of cysts in OA is not entirely clear but is most 
probably due to synovial fluid intrusion or bone remodelling (or a combination) (35-37). 
Hence, the erosions, cysts and BMLs are possibly inter-related. Cysts and erosions may also 
be surrounded by BMLs making the distinction more difficult. In knee OA, cysts and BMLs 
have been combined into one feature in the BLOKS and MOAKS (153, 154). Whether these 
features have similar prognostic and clinical value in hand OA should be explored before 
one can consider merging the two features into one.  
We used all available MRI planes for assessment of bone formation. Hence, both “real” 
intra-articular osteophytes at the joint margins and traction spurs at the insertions of the 
extensor tendon were scored as osteophytes despite different underlying mechanisms (167). 
The initiation of the “real” intra-articular osteophytes is associated with proliferation of 
mesenchymal cells from the periosteum and synovium at the joint margins, which 
subsequently differentiate into chondrocytes. These cells undergo hypertrophy and create 
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skeletal outgrowths after a process of endochondral ossification. The chondral hyperplasia 
will in practice grow in the direction of least resistance, and anatomical studies of the finger 
joints have shown that a “window” exists between the extensor tendon and the collateral 
ligaments (106). It has been suggested that local biomechanical factors are important to the 
formation of osteophytes, and there is evidence that the osteophytes in fact contribute to 
maintenance of joint stability. Hence, it is unclear whether osteophytes represent 
pathological joint alterations or normal remodelling processes secondary to the OA changes 
in the joint (32, 38).  
Enthesophytes around the finger joints are seen as bone formation at the insertions of the 
extensor tendons and possibly along the midshaft, as physiological responses to excessive 
tension or contracture, and can be identified by its location within a collagenous structure 
(106). Previous studies have suggested an association between enthesopathic changes and 
OA (211), but Gibson et al. found no association between enthesopathic changes in the hand 
and knee (212, 213). Whether these enthesopathic changes play a role in hand OA is 
unclear.  
Direct assessment of the cartilage in these small finger joints was difficult due to suboptimal 
resolution of the MRI scans. The cartilage appears grey on the STIR images and may be 
difficult to delineate from the black cortical bone. On the GRE fat-saturated images, the 
cartilage is bright and can be easily delineated from the bone. However, it was in this study 
not possible to delineate the two layers of cartilage and the synovial fluid. Hence, even if 
MRI is capable of directly visualise the cartilage, JSN was defined based on the inter-bone 
distance in our proposed scoring system (paper I).  
In summary, we have proposed a preliminary MRI scoring system for hand OA, which 
contains both structural and inflammatory OA features. The proposed scoring system is 
extensive and time-consuming (paper I). We did not measure the exact time that was 
required for assessment of one MRI scan, but 30-60 minutes was usually necessary 
depending on the severity of disease seen on the MRI scans (i.e., longer time was required 
for patients with severe disease). Increased feasibility can potentially be obtained by 
exclusion of non-relevant features, collapse of features and scoring at joint level (i.e., not 
the proximal and distal part of the joint separately).  
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5.2.2 Reliability of the MRI scoring system for hand OA 
In this thesis, the status scores were assessed independently, and we used SDD in order to 
test whether the differences between two independent status scores differed from zero. SDD 
should not be confused with smallest detectable change (SDC), which is used in 
longitudinal settings when the images are presented to the reader in pairs with or without 
known time sequence (i.e., the two obtained scores are not assessed independently) (189).  
The intra-reader reliability for inflammatory features was only moderate (paper I), while the 
inter-reader reliability (based on the results from the first reading) was good to very good. 
This is possibly due to the use of different radiographic imaging software for the first and 
second reading (PACS and OsiriX respectively). The intra-reader reliability (IKH) reported 
in paper II and III was very good for synovitis but moderate for flexor tenosynovitis. In this 
case, the same software (PACS) was used for both the first and second reading. These 
results suggest that use of different imaging software may affect the impression of Gd 
enhancement and should preferably be invariable in a study. In summary, synovitis can 
probably be assessed with good reliability, while the assessment of flexor tenosynovitis is 
less reliable and possibly redundant. 
5.2.3 Spectrum and severity of MRI findings in hand OA 
Key hand OA features, such as osteophytes, JSN and erosions, were frequently present 
(paper II). This section will focus on synovitis and BMLs, which cannot be visualised by 
CR. Structural features, which can be visualised by both MRI and CR, will be discussed in 
the next section.  
OA has traditionally been considered as a non-inflammatory disease. However, 
inflammation is increasingly recognised in both early and late stages of the disease 
contributing to symptoms and progression of OA (214). In this thesis, we found a very high 
prevalence of MRI-defined synovitis with Gd enhancement (grade 1-3: 66% of the joints, 
grade 2-3: 22% of the joints) (paper II). This number is substantially higher than the number 
of joints with MRI-defined synovitis reported by Wittoek et al. (20%) (201), whereas Kwok 
et al. reported even higher numbers (202).  
Several studies have examined the prevalence of US-detected synovitis in patients with 
hand OA (215-219). In line with our results, Keen et al. demonstrated grey scale synovitis 
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(a combination of synovial thickening and effusion) in 53% of the joints (215). Other 
studies have suggested that joint effusion is more prevalent than synovial thickening (216, 
217), while power Doppler activity is less common (215-218). However, results are not 
completely consistent across studies (219). The differences between the US studies may be 
due to varying disease severity in the patient populations, the US technique and 
interpretation of the findings. All US studies reported lower prevalence estimates of 
synovitis than in this thesis (paper II), despite the fact the presence of MRI-detected 
synovitis by definition required both synovial thickening and Gd-enhancement (paper I). A 
higher sensitivity of MRI in comparison to US in detection of synovitis has also been 
reported by Wittoek et al. (201).  
We found a high proportion of mild MRI-defined synovitis also in joints with no/doubtful 
OA (KL grade < 1) (paper II), as previously shown for US-detected effusion and synovitis 
in hand OA (217) and also for MRI-detected synovitis in knee OA (220). Synovitis was 
most common in joints with mild radiographic OA (KL grade = 2). Wittoek et al. found that 
US-detected effusion, synovitis and power Doppler activity were common in all phases of 
radiographic OA (17), but most prevalent in erosive joints (E phase) and slightly lower in 
joints that were remodelled (R phase) (217). Similar results were shown for MRI-defined 
synovitis by Kwok et al., although the prevalence of synovitis was very high in all phases 
(202). These results may suggest a “burn-out” of inflammation in later stages of the disease 
or possibly more easily detection of synovitis in joints with more anatomical space. 
However, the association between synovitis and damage needs to be further investigated in 
longitudinal studies. In knee OA, Benito et al. showed that cell infiltration and vascular 
proliferation were more frequent in synovial biopsies from patients with early OA (less than 
1 year symptom duration) than in severe late OA (221). However, other studies have shown 
that synovitis is most frequent in severe knee OA (222, 223).  
Previous MRI studies have shown that the thin synovial membrane in the MCP and wrist 
joints can show low-grade post-Gd enhancement also in persons without clinical OA or 
inflammatory disease (224, 225). Similarly, studies of healthy controls using US have found 
synovial hypertrophy and effusion of the DIP and PIP joints (215, 218). However, the 
selection of the control groups may have biased the results, and some cases among the 
healthy individuals might be in a very early stage of hand OA. Hence, our definition of 
synovitis was based on the thickness of the synovial membrane in combination with Gd 
enhancement. Whether the thickness of the synovium was greater than normal was based on 
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comparison with images in the atlas. However, one may question whether grade 1 
represents pathology or is within the normal variations.  
We found a low prevalence of BMLs (13% of the joints) (paper II) compared to findings 
reported by Wittoek and Kwok et al. (54% and 27% respectively) (201, 202). Both these 
studies were performed with use of a 3.0 T MRI scanner, which may have contributed to 
higher sensitivity in detection of BMLs. Furthermore, Wittoek et al. had a slice thickness of 
only 1 mm, while Kwok et al. had similar slice thickness as in our study (3 mm). We found 
the highest prevalence of BMLs in joints with KL grade 3-4, and moderate to large BMLs 
were very uncommon in joints without radiographic OA (paper II). These results are in line 
with previous studies in knee OA, suggesting that BMLs are manifestations of bone trauma 
related to increased biomechanical loading (e.g., meniscal pathology and malalignment) 
(226-229). Histological studies in knee OA have confirmed the presence of necrotic, 
remodelled trabeculae, bone marrow necrosis and/or fibrosis, which are consistent with 
ongoing local bone trauma and repair (146).  
We found that the collateral ligaments appeared disrupted in 41% of the normal joints (KL 
grade = 0), and in 90% of the joints with radiographic moderate/severe OA (paper II). These 
results are in line with the results from Tan et al. showing that ligament abnormalities were 
present at hrMRI scans in both early (symptom duration less than 1 year) and chronic hand 
OA (symptom duration more than 1 year) (110). Other structural abnormalities, such as 
BMLs, erosions and osteophytes, were seen in close anatomic relationship to the ligaments, 
and Tan et al. hypothesised that the collateral ligaments could possibly play a role in the 
pathogenesis of OA. However, ligament abnormalities were also frequent in the elderly 
controls, and these abnormalities could therefore possibly also be age-related (110).  
Flexor tenosynovitis was infrequently present (19% of the joints) and was not associated 
with radiographic severity (paper II). These findings may suggest that flexor tenosynovitis 
is not related to the OA process.  
Histology represents the gold standard for the examination of BMLs and synovitis. Tan et 
al. also performed a combined MRI and histological study (207), but interpretation of the 
results is limited by the fact that the MRI scans and histological sections were not from the 
same subjects. Lewis et al. correlated the MRI appearance of the PIP joints of cadavers with 
histology of the same specimens (230). However, they focused on normal anatomy and did 
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not explore the histological content of MRI-defined BMLs or synovitis. Hence, the 
histological content of the MRI-defined BMLs and synovitis in hand OA remains unclear.  
5.2.4 Validity of MRI against CR 
MRI was in this study more sensitive than CR in detection of erosions and osteophytes but 
not of JSN, cysts and malalignment (paper II). These results are discussed in this section in 
the context of other studies, and possible explanations for our findings are presented.  
The classification of erosive hand OA has traditionally been based on the presence of 
radiographic central erosions, which typically show classic "seagull wing" patterns. We 
found good agreement between MRI-defined attrition and radiographic central erosions 
(paper II). However, significantly more joints had MRI-defined erosions and/or attrition 
(52% of the joints) than marginal or central erosions detected by CR (25% of the joints). 
These numbers are in line with previous MRI studies in hand OA (150, 201, 202) 
supporting the validity of our results.  
The hand radiographs were initially only scored for central erosions according to the 
OARSI atlas (170). We chose to re-evaluate all joints without radiographic central erosions 
for presence of marginal erosions in order to not underestimate the prevalence of 
radiographic erosions. However, marginal erosions were found in only 39 of 677 joints. 
Erosions may be located on the dorsal or volar side of the joint and may therefore be less 
visible on CR. 
We chose to score MRI-defined attrition and focal erosions separately, since they perhaps 
have a different pathogenesis. Previous studies on radiographic hand OA have shown that 
cartilage loss precedes radiographic erosive evolution (17, 34), suggesting that 
biomechanical factors may play a role in the development of these erosions. However, 
studies using hrMRI have also identified periarticular/marginal erosions (110, 150), which 
were associated with pathological collateral ligaments and synovitis. These marginal 
erosions have traditionally not been assessed in hand OA, and future longitudinal studies 
should explore their role in hand OA with regard to the pathogenesis of OA and prognostic 
value. Small erosion-like lesions in the metacarpal and wrist bones have also been shown in 
healthy controls, but they were mainly not contrast-enhancing (224).  
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MRI was in our study more sensitive than CR in detection of osteophytes (86% and 39% of 
the joints respectively) (paper II). Kwok et al. had similar findings (202), whereas Wittoek 
et al. found similar numbers of joints with osteophytes on MRI and CR (201). The higher 
sensitivity of MRI could possibly be explained by the multiplanar demonstration of the joint 
by MRI. All these three studies used radiographs with traditional posteroanterior view, 
which can project “real” intra-articular osteophytes at the medial and lateral joint margins. 
The sagittal planes of MRI and radiographs with oblique or lateral view are able to visualise 
traction spurs. Consistent with the findings reported by Tan et al. (207), we frequently 
found osteophytes at the insertion site of the extensor tendon. Although the pathogenesis of 
the intra-articular osteophytes and traction spurs may differ, they were combined into one 
feature reflecting bone formation in order to not introduce a too extensive scoring system.  
In contrast to our findings, Wittoek et al. did not find a higher sensitivity of MRI in 
detection of osteophytes and argued that this could be due to the signal void of densely 
packed calcium in osteophytes (201). However, delineation of the dark osteophytes is still 
possible if adjoining tissue demonstrate high signal intensity. One limitation of the study by 
Wittoek et al. is the lack of a standardised scoring method for the assessment of 
osteophytes. Thus, it remains unclear how they defined osteophytes and which sequences 
and planes that were used for this assessment. Too conservative scoring of radiographic 
osteophytes according to the OARSI atlas may also have contributed to the difference 
between MRI and CR. The OARSI atlas shows examples of clear definite osteophytes, and 
doubtful ossicles at the corners were not scored as present osteophytes (170).  
The dark appearance of bone on the GRE fat-saturated sequence complicated the distinction 
between bone proliferation and soft tissue such as ligaments and tendons, which may have 
led to an overestimation of bone proliferation. If the bone proliferations contain trabecular 
bone (i.e., only large osteophytes), a non-fat suppressed sequence could have simplified the 
distinction between bone and soft tissue (162). 
The agreement between MRI-defined JSN and radiographic JSN was moderate. JSN was 
more common on CR (80% of the joints) than on MRI (68% of the joints), which may be 
due to apparent radiographic JSN in normal joints with flexion deformities. On the other 
hand, MRI is able to demonstrate intra-articular osteophytes (and thus cartilage defects) that 
are not visualised on CR, which may contribute to the decreased specificity of MRI. 
 66 
Cysts were infrequently seen by both MRI and CR, but the agreement was poor. The 
majority of the joints with cysts only on CR demonstrated erosions on the MRI scans. As 
previously discussed, it might be difficult to judge whether a cortical break is present or not 
on the MRI.  
Malalignment was similarly more common on CR (12% of the joints) than MRI (7% of the 
joints). The higher sensitivity of CR may be due to a too strict definition of MRI-defined 
malalignment (> 15 degrees angulation in the frontal plane). No cut-off for the angulation is 
defined in the OARSI atlas (170).  
We used CR as our comparator (“gold standard”) in this study. However, we know from 
studies in RA that CR is inadequate for defining erosions and is therefore not optimal for 
comparison with MRI (104). The most convincing comparators for MRI features would 
have been histological evidence or computed tomography (CT), but these were not available 
in the cohort used in this thesis. Histology of joints is usually only available from cadavers 
or after surgery. Computerised tomography (CT) provides multiplanar imaging with the 
advantages of good visualisation of bony anatomy, and future studies should therefore 
ideally use CT as the gold standard for assessment of erosions, cysts and osteophytes.  
5.2.5 Associations between MRI findings and measures of pain  
A systematic review from 2006 revealed evidence for a positive association between 
radiographic hand OA and hand pain, but large variation among studies was also reported 
(231). These results may suggest that other structures than those seen by CR are important 
for the experience of pain in hand OA.  
All MRI features (except cysts) were associated with tenderness upon palpation in the 
univariate analyses (paper III). However, it is important to notice that OA is a disease 
affecting the whole joint organ. Several features are associated with each other and therefore 
often co-occurring, which may lead to problems with confounding. Hence, we performed 
multivariate analyses in order to more accurately assess the direct associations between the 
various MRI features and joint tenderness. Our final multivariate model included 
osteophytes, erosions, bone attrition, synovitis and BMLs (paper III). These findings 
support the notion that the occurrence of pain is multifactorial with contributions from 
several features in the whole joint organ.  
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Subchondral bone, a richly innervated tissue, is thought to be involved in pain generation, 
which was supported by a positive association between bone formation and damage with 
joint tenderness (although the association was not statistically significant for osteophytes). 
Osteophytes may cause joint pain either by stretching nerve endings in the 
periosteum/capsule or be a result of microfractures of the bone trabeculae within the spur 
(232). Our results are in line with a recent study by Kortekaas et al. showing an association 
between radiographic and US-detected osteophytes and tenderness upon palpation in finger 
joints in hand OA, which was independent of radiographic JSN and US-detected 
inflammation (233). The OR detected in this study was of higher magnitude compared to 
our results, which may be explained by residual confounding in their model (since BMLs 
and attrition/erosions were not included in the model) (233). Keen et al. also found that 
tender and painful joints were more likely to demonstrate US-detected osteophytes (215). 
However, Yusuf et al. concluded that there was limited evidence for an association between 
MRI-defined osteophytes and pain in a systematic review of knee OA (234).  
MRI-defined bone attrition and erosions were the only structural features that were 
significantly (p < 0.05) associated with joint tenderness. Previous studies on radiographic 
hand OA have shown that patients with erosive hand OA experience more pain and 
functional limitation than patients with non-erosive OA (29, 235). However, the patients 
with erosive hand OA had also a higher burden of disease, and most differences disappeared 
or were diminished after correction for the number of finger nodes (235). Our results are 
also in line with cross-sectional studies in knee OA showing an association between bone 
attrition and knee pain (236, 237).  
This thesis is the first to show an association between BMLs and tenderness in hand OA, 
which remained borderline statistically significant in the multivariate model. BMLs may 
cause pain due to “bone angina”, i.e., stagnation of blood flow through the thickened 
subchondral bone trabeculae, which are the consequence of healing and remodeling of 
microfractures (238, 239). Hunter et al. confirmed a link between elevated intraosseous 
venous pressure and BMLs in knee OA (240). However, the pathophysiology behind the 
observed association between BMLs and pain is still elusive (241).  
We found a significant association between MRI-defined synovitis and pain in hand OA, 
which supports previous studies using US (215, 216). However, the analyses in these 
previous studies were not adjusted for structural features and the direct effect of 
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inflammation on pain is therefore difficult to evaluate due to possible confounding. We 
found significant associations between synovitis and joint tenderness independent of other 
MRI features and radiographic severity, which strengthens the hypothesis of inflammation 
as a target in hand OA (89, 90). Keen et al. performed a four-week observational study on 
parenteral corticosteroids in hand OA, but they found no statistically significant reduction in 
US-detected synovitis (242). However, whether MRI synovitis is more sensitive to change 
and corresponds to clinical improvement needs to be assessed in future studies. 
BMLs and synovitis seem to be the features that are most consistently associated with pain 
in knee OA (156, 220, 234, 243-248). A recent systematic review concluded that knee pain 
in OA was associated with BMLs and effusion/synovitis with moderate evidence, while the 
level of evidence for other MRI features was limited or conflicting (234). However, results 
are conflicting especially for BMLs (249-251), and several studies are limited by inadequate 
adjustment for demographic factors, other MRI features and/or radiographic severity, which 
may represent confounding factors. The lack of correlation between the severity of synovitis 
and the severity of knee pain further emphasise that not only synovitis contributes as a 
source of OA pain (246).  
We found no independent association between JSN and pain, which was expected since the 
cartilage has no neural innervations. Cartilage damage in itself is therefore an unlikely 
source of pain in OA. However, a recent study by Kortekaas et al. showed an association 
between radiographic JSN and pain, independent of osteophytes and US-detected 
inflammation (233). Keen et al. also found that tender and painful tender joints were more 
likely to have US-detected JSN (215). These observed associations between JSN and pain 
are probably indirect and may possibly be mediated through attrition (central erosions), 
synovitis and/or BMLs acting as intermediate factors on the path between JSN and pain.  
Flexor tenosynovitis did not remain in the final multivariate model for the association to 
joint tenderness. Based on our results showing moderate reliability, infrequent appearance 
and no association to radiographic severity or joint tenderness (paper I-III), this feature can 
possibly be removed from the proposed scoring system (paper I).  
In line with previous studies using US and CR (215, 233), we found significant associations 
between MRI features and tenderness at the individual joint level, while the associations 
between the amount of MRI abnormalities and patient-reported pain (as measured by 
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AUSCAN) were much weaker (paper III). First of all, person-related psychosocial factors 
influence the report of pain and physical disabilities (241), while this influence is smaller on 
the analyses at individual joint level. Anxiety and depression are strong predictors of 
functional impairment and pain in OA and may therefore represent confounding factors for 
the association between OA features and pain (252). A study in knee OA elegantly showed 
that radiographic knee OA was strongly associated with pain when the analyses were 
performed in subjects that were discordant for pain status, and hence the analyses were 
controlled for person confounding (253). Secondly, we had information about MRI 
pathology in the DIP and PIP joints of the dominant hand only. Hence, MRI pathology in 
the non-dominant hand as well as in the MCP and thumb base joints of the dominant hand 
may also have affected the level of self-reported symptoms (254). Thirdly, studies have also 
shown great variations in OA pain, also within the same day (255, 256). Moreover, 
peripheral and central mechanisms of sensitisation may occur, leading to increased pain 
sensation (hyperalgesia and allodynia) and possibly pain responses from regions of the body 
remote from the inflamed joint (i.e., referred pain). The pain may also be influenced by the 
use of analgesia, and patients with severe disease may also report low levels of pain during 
activities if they avoid specific activities due to the awareness of pain. 
5.2.6 Associations between MRI findings and measures of physical 
function 
Previous studies of radiographic hand OA have shown inconsistent results for an association 
between radiographic hand OA and hand function, ranging from no association to moderate 
association (231). We found only limited evidence for an association between MRI features 
and markers of impairment and activity, but structural features such as bone formation and 
bone damage seemed to be most important for these associations (paper III).  
The lack of significant associations may, as mentioned in the previous chapter, be due to 
person-related psychosocial factors that influence the self-reported physical disabilities 
(241), avoidance of specific activities due to pain or inability to perform the specific tasks, 
the use of remedies and imaging of the DIP and PIP joints of the dominant hand only.  
Objective hand function tests are less related to person-related psychosocial factors as 
compared to self-reported questionnaires. In this thesis (paper III), we examined the 
association between the MRI features and grip strength as an objective measure of hand 
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function. Previous studies have shown that grip strength is more closely related to OA in the 
more proximal joints including the MCP joints. Chaisson et al. found that high grip strength 
was a risk factor for incident OA in the thumb base and MCP (64), and it is possible that 
OA in these joints will have more impact on the impairment of grip strength than the DIP 
and PIP joints (58, 257). Thumb base involvement in symptomatic hand OA has also been 
associated with higher levels of self-reported physical disability than OA in the 
interphalangeal joints (254). However, in contrast to previous studies, we found a stronger 
association between radiographic OA in the DIP joints and grip strength than for OA in the 
thumb joints and grip strength (data not shown in paper III).  
FIHOA was the only questionnaire among the self-reported instruments that was able to 
show significant associations to the MRI features, which may indicate that characteristics of 
the various outcome measures can affect the results. We have previously examined the 
construct validity of the AUSCAN physical, AIMS-2 hand/finger and FIHOA subscales. 
None of the subscales were unidimensional, since they contained features about tasks 
requiring grip strength as well as tasks requiring precision grip representing two separate 
constructs. The contribution of grip strength and precision items varied across the 
instruments with the AUSCAN having relatively more items concerning grip strength and 
the AIMS-2 and FIHOA having relatively more precision items (122).  
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6. Conclusions 
6.1 Answers to research questions 
We were able to provide answers to the specific research questions presented in section 2.2:  
− To address the general aim, we developed an atlas presenting example images of MRI 
features with different grades of pathology in DIP and PIP joints in hand OA (paper I).  
− The intra-reader and inter-reader reliability for status scores of MRI features in hand OA 
were generally good to very good (paper I).  
− Structural MRI features such as osteophytes, JSN, erosions/attrition, ligament 
discontinuity as well as synovitis were frequently present in hand OA patients. 
Malalignment, cysts, BMLs and flexor tenosynovitis were less common (paper II-III). 
− MRI pathologies were generally most common in DIP and PIP joints with 
moderate/severe radiographic OA, whereas synovitis was most common in mild 
radiographic OA. Structural hand OA features such as osteophytes, JSN and erosions as 
well as mild synovitis were common also in joints rated without/doubtful radiographic 
OA (paper II). 
− Agreement between MRI-defined attrition and radiographic central erosions was 
substantial, while the agreement was weaker when both central and marginal erosions 
were assessed. Moderate agreement was found for detection of osteophytes and JSN, but 
the percentage of close agreement was very high. Only poor to moderate agreement 
between MRI and CR was shown for cysts and malalignment (paper II).  
− MRI was much more sensitive than CR in detection of erosions and osteophytes, while 
the specificity was lower. The sensitivity and specificity in detection of MRI-defined 
JSN was good in comparison to radiographic JSN. The specificity of MRI for detection 
of cysts and malalignment was very good, while the sensitivity was lower. Several 
radiographic cysts were scored as erosions on MRI (paper II).  
− MRI-defined attrition, erosions, synovitis and BMLs showed the strongest associations to 
tenderness in the same joint (paper III).  
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− The amount of MRI features was not associated to patient-reported pain. There was a 
tendency towards an association between structural MRI features and patient-reported 
functioning and grip strength (paper III).  
 
6.2 Clinical implications 
This thesis provides results that are of potential importance to clinicians. We have shown 
that both structural and inflammatory features could reliably be assessed by MRI.  
MRI proved to more sensitive in detection of structural hand OA features compared to CR. 
Further, both structural features as well as synovitis were frequently detected by MRI in 
joints with no or only doubtful radiographic OA, suggesting that OA may be present even 
though CR shows limited findings.  
Synovitis, erosions, attrition and BMLs were associated with pain in hand OA independent 
of other structural features. Whether these could represent targets for treatment in hand OA 
should be further explored.  
We believe that MRI can contribute the better knowledge about the sources of pain in hand 
OA and possibly represent an outcome measure in clinical trials.  
 
7. Errata 
There was no overlap between the slices provided by the Dixon sequence (paper I, page 
1034).  
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